<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id><journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id><journal-title-group><journal-title>Frontiers in Neuroscience</journal-title></journal-title-group><issn pub-type="ppub">1662-4548</issn><issn pub-type="epub">1662-453X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40400620</article-id><article-id pub-id-type="pmc">PMC12093412</article-id><article-id pub-id-type="doi">10.3389/fnins.2025.1570173</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neuroscience</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>From the gut to the brain, mechanisms and clinical applications of &#x003b3;-aminobutyric acid (GABA) on the treatment of anxiety and insomnia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Chengji</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>You</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Sun</surname><given-names>Tao</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1046684/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Center for Precision Medicine, School of Medicine and Biomedical Sciences, Huaqiao University</institution>, <addr-line>Xiamen</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>GeneYoung Biopharmaceuticals</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by" id="fn0001"><p>Edited by: Avinash Veerappa, University of Nebraska Medical Center, United States</p></fn><fn fn-type="edited-by" id="fn0002"><p>Reviewed by: Sushil Shakyawar, University of Nebraska Medical Center, United States</p><p>Nana Zhang, Xiamen University, China</p></fn><corresp id="c001">*Correspondence: Tao Sun, <email>taosun@hqu.edu.cn</email></corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>19</volume><elocation-id>1570173</elocation-id><history><date date-type="received"><day>03</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>22</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Jiang, Chen and Sun.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Jiang, Chen and Sun</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Anxiety and insomnia are prevalent global mood disorders, and affect approximately 4 and 10 out of every 100 individuals, respectively. Common abnormal brain activity and altered neural circuitries are detected in patients with anxiety disorders and insomnia, suggesting overlapping pathogenesis in these two disorders. Promisingly, GABA from dietary supplements and GABA produced by gut microbiota have shown significant treatment effects in anxiety and insomnia. This review summarizes neurological mechanisms causing anxiety and insomnia, reveals cellular pathways transferring GABA from the gut to the brain, and delivers the therapeutic potential of gut derived GABA for anxiety and insomnia. Moreover, this review proposes emerging therapeutic strategies utilizing engineered GABA-producing bacteria to target anxiety and insomnia, and highlights the potential of live biotherapeutics as novel interventions for mood disorders.</p></abstract><kwd-group><kwd>GABA</kwd><kwd>anxiety</kwd><kwd>insomnia</kwd><kwd>gut microbiota</kwd><kwd>probiotics</kwd><kwd>genetic engineered bacteria</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the Scientific Research Funds of Huaqiao University (Z16Y0017, TS), and the National Natural Science Foundation of China (32271002, TS).</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="3"/><equation-count count="0"/><ref-count count="154"/><page-count count="13"/><word-count count="11665"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Gut-Brain Axis</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1"><label>1</label><title>Introduction</title><p>The global prevalence of anxiety disorder is increasing, particularly in cities with greater levels of stress and fast-paced lifestyles. In 2024, nearly 275 million people are suffering from anxiety disorders, accounting for approximately 3.5% of the global population (<xref rid="ref23" ref-type="bibr">Calm, 2024</xref>). Moreover, about 10% of adults are affected by insomnia disorders, and an additional 20% experiences occasional insomnia symptoms worldwide (<xref rid="ref86" ref-type="bibr">Morin and Jarrin, 2022</xref>). Anxiety disorders and sleep disturbances exhibit a bidirectional relationship, where anxiety-induced hyperarousal disrupts sleep architecture, and sleep deprivation amplifies emotional vulnerability (<xref rid="ref13" ref-type="bibr">Bragantini et al., 2019</xref>; <xref rid="ref101" ref-type="bibr">Pillai et al., 2014</xref>; <xref rid="ref110" ref-type="bibr">Sadeh et al., 2004</xref>). Specifically, sleep deprivation increases cortisol levels, amplifies emotional procession of the limbic system and the salience network involved in cognitive control (dorsal anterior cingulate cortex and anterior insula), and creates a vicious cycle of hyperarousal and anxious apprehension (<xref rid="ref24" ref-type="bibr">Carlisi et al., 2017</xref>; <xref rid="ref97" ref-type="bibr">Palmer and Alfano, 2020</xref>; <xref rid="ref143" ref-type="bibr">Yoo et al., 2007</xref>). Conversely, anxiety disorders disrupt sleep architecture by reducing slow-wave sleep and increase nocturnal awakenings through noradrenergic hyperactivity in the locus coeruleus (<xref rid="ref26" ref-type="bibr">Chellappa and Aeschbach, 2022</xref>; <xref rid="ref40" ref-type="bibr">Gong et al., 2021</xref>).</p><p>Pathogenic studies have shown that anxiety and insomnia share similar biological mechanisms (<xref rid="ref87" ref-type="bibr">Morris et al., 2020</xref>; <xref rid="ref130" ref-type="bibr">Van Someren, 2021</xref>). The locus coeruleus (LC) can activate the amygdala by releasing norepinephrine (NE), thereby inducing anxiety and triggering the body&#x02019;s anxious response (<xref rid="ref124" ref-type="bibr">Su&#x000e1;rez-Pereira et al., 2022</xref>). The locus coeruleus also acts as the control center for wakefulness. Its specialized nerve cells release norepinephrine when one is awake, like an internal &#x0201c;alarm system.&#x0201d; During deep and slow-wave sleep, these cells quiet down significantly, and fall silent completely during rapid eye movement (REM) sleep, the stage mostly associated with vivid dreaming (<xref rid="ref132" ref-type="bibr">Verret et al., 2006</xref>). Thus, the LC serves as a pivotal point where the two disorders converge.</p><p>Another potential pivotal point is the hypothalamic&#x02013;pituitary&#x02013;adrenal (HPA) axis. Anxiety and insomnia patients commonly exhibit activation of the HPA axis, characterized by elevated hormone levels such as cortisol (<xref rid="ref55" ref-type="bibr">Juruena et al., 2020</xref>; <xref rid="ref148" ref-type="bibr">Zhang et al., 2014</xref>). Elevated cortisol levels enhance the amygdala&#x02019;s sensitivity to threat signals (<xref rid="ref107" ref-type="bibr">Roberts et al., 2022</xref>). Prolonged high cortisol exposure keeps it in &#x0201c;hyper-vigilance,&#x0201d; causing continuous anxiety even without real threats. Moreover, high cortisol can activate the amygdala, and reduce slow-wave sleep (<xref rid="ref17" ref-type="bibr">Buckley and Schatzberg, 2005</xref>; <xref rid="ref137" ref-type="bibr">Wong et al., 2000</xref>). Additionally, increased cortisol damages prefrontal cortex neurons and weakens its inhibitory function on the amygdala, impairing one&#x02019;s emotion regulation ability (<xref rid="ref104" ref-type="bibr">Ren et al., 2022</xref>).</p><p>Currently, besides behavioral interventions such as mental therapy and exercise, medication remains an effective treatment for anxiety and insomnia (<xref rid="ref57" ref-type="bibr">Kandola and Stubbs, 2020</xref>; <xref rid="ref105" ref-type="bibr">Riedel et al., 2024</xref>; <xref rid="ref113" ref-type="bibr">Shaha, 2023</xref>; <xref rid="ref134" ref-type="bibr">Vu and Conant-Norville, 2021</xref>). Many medications have been developed, with several already commercialized and available on the market. For example, classic medications such as barbiturates and benzodiazepines are known to possess sedative and hypnotic effects (<xref rid="ref11" ref-type="bibr">Bormann, 1988</xref>; <xref rid="ref12" ref-type="bibr">Bowery et al., 1979</xref>; <xref rid="ref116" ref-type="bibr">Sigel and Ernst, 2018</xref>). However, the current medications for anxiety and insomnia often cause various side effects. For instance, benzodiazepines can cause sedation, slowed reaction time, and impaired memory and psychomotor function (<xref rid="ref41" ref-type="bibr">Greenblatt et al., 2020</xref>). Therefore, the development of a more natural and less harmful medication holds significant promise for the treatment of anxiety and insomnia.</p><p>As a natural neurotransmitter, &#x003b3;-aminobutyric acid (GABA) is promoted for its benefits in addressing anxiety and insomnia (<xref rid="ref43" ref-type="bibr">Hepsomali et al., 2020</xref>; <xref rid="ref91" ref-type="bibr">Ngo and Vo, 2019</xref>). The efficacy of orally administered GABA is supported by positive consumer reviews and clinical experiments, suggesting its promising therapeutic effects on anxiety and insomnia symptoms (<xref rid="ref91" ref-type="bibr">Ngo and Vo, 2019</xref>). Dietary sources that are rich in GABA and GABA-producing probiotics also display significant therapeutic effects on anxiety and insomnia (<xref rid="ref76" ref-type="bibr">Liwinski et al., 2023</xref>; <xref rid="ref121" ref-type="bibr">Strandwitz, 2018</xref>).</p><p>Because the association of gut microbiota in human health and diseases is well recognized, it is timely to better understand how gut derived GABA may function in humans. Moreover, in this review, orally administered GABA, GABA from GABA-rich food, and GABA from GABA-producing probiotics are collectively referred to as &#x0201c;gut derived GABA.&#x0201d; This review explores production, absorption and transmission of gut derived GABA, clarifies its potential mechanisms in alleviating anxiety and insomnia, and discusses future applications for optimized production and clinical use.</p></sec><sec id="sec2"><label>2</label><title>Anxiety and insomnia</title><sec id="sec3"><label>2.1</label><title>Anxiety</title><p>Anxiety disorder represents a prevalent category of mood disorders (<xref rid="ref19" ref-type="bibr">Byrd and Brook, 2014</xref>). While acute anxiety involves a sudden onset of intense fearful experiences, chronic anxiety is the most common presentation of anxiety disorders, with symptoms including persistent and unwarranted worries, fatigue, insomnia and profound distress (<xref rid="ref92" ref-type="bibr">Nutt, 2005</xref>; <xref rid="ref108" ref-type="bibr">Robinson et al., 2019</xref>). A variety of risk factors, including family issues, environmental exposures, and perceived threats, can contribute to the development of anxiety (<xref rid="ref135" ref-type="bibr">Warner and Strawn, 2023</xref>).</p><p>The neural circuitry associated with anxiety has been studied. The amygdala plays a crucial role in emotion generation, recognition and regulation, as well as in controlling learning and memory, and fear response through receiving and responding information from the locus coeruleus (LC) and other sensory inputs (<xref rid="ref65" ref-type="bibr">Krettek and Price, 1978</xref>; <xref rid="ref124" ref-type="bibr">Su&#x000e1;rez-Pereira et al., 2022</xref>). For transient panic, the basolateral amygdala (BLA) integrates sensory information from the environment and activates the central amygdala (CE). Subsequently, the central nucleus of the amygdala (CeA) triggers defensive responses by projecting to brain regions such as the ventral striatum, hippocampus, lateral hypothalamus (LH) and surrounding areas (<xref rid="ref70" ref-type="bibr">LeDoux, 2000</xref>). For persistent anxiety, the bed nucleus of the stria terminalis (BNST), which is part of an extended amygdala, is more directly involved and closely coupled with the CE (<xref rid="ref154" ref-type="bibr">Zhu et al., 2024</xref>).</p><p>Under high-pressure conditions, the LC enhances amygdala function while simultaneously attenuates the prefrontal cortex (PFC) function to facilitate fear learning. Conversely, under low-pressure conditions, the LC enhances PFC function, thereby increasing the inhibitory effect of the medial prefrontal cortex (mPFC) on the amygdala from top to bottom, and subsequently promoting fear extinction (<xref rid="ref39" ref-type="bibr">Giustino and Maren, 2018</xref>).</p><p>Moreover, the hippocampus receives signals from the BLA and stores fear and long-term anxiety signals (<xref rid="ref42" ref-type="bibr">Hajisoltani and Meftahi, 2024</xref>). These memories persist for a period and can be reactivated by a similar context, even if the individual is no longer directly in that situation (<xref rid="ref25" ref-type="bibr">Chaaya et al., 2018</xref>). In addition to anxiety signals from the locus coeruleus, sensory information from visceral changes, such as heart rate, gastrointestinal responses and blood pressure, can be transmitted to the mPFC via the anterior insula, thereby contributing to the maintenance of anxiety (<xref rid="ref133" ref-type="bibr">Vertes, 2004</xref>). Disrupted limbic-hypothalamic&#x02013;pituitary&#x02013;adrenal axis (LHPA), commonly referred to as the HPA axis, is also involved in anxiety disorders. Patients with anxiety exhibit elevated levels of plasma cortisol, which is released from the adrenal gland, potentially intensifying feelings of fatigue due to the acceleration of glycogen metabolism (<xref rid="ref55" ref-type="bibr">Juruena et al., 2020</xref>).</p></sec><sec id="sec4"><label>2.2</label><title>Insomnia</title><p>Insomnia is the most prevalent sleep disorder in industrialized countries, characterized by symptoms such as dissatisfaction with sleep quality or duration, difficulty falling asleep at bedtime, waking up in the middle of the night or too early in the morning (<xref rid="ref84" ref-type="bibr">Morin and Benca, 2012</xref>). Although symptoms of insomnia primarily occur at night, many individuals also experience daytime cognitive impairments, such as difficulties with attention, concentration and memory, as along with mood disturbances like irritability and dysphoria (<xref rid="ref18" ref-type="bibr">Buysse et al., 2007</xref>). Even though a significant number of adults are suffering from severe insomnia, less than 15% of those receive proper treatment (<xref rid="ref8" ref-type="bibr">Bhat et al., 2008</xref>).</p><p>Dysfunction of the wakefulness and sleep neural systems is the major cause of insomnia (<xref rid="ref106" ref-type="bibr">Riemann et al., 2010</xref>). The wakefulness regulatory system comprises two pathways (<xref rid="ref111" ref-type="bibr">Saper et al., 2005</xref>). One pathway involves NA neurons in the LC, serotonin (5-HT) neurons in the raphe nuclei, histaminergic (His) neurons in the tuberomammillary nucleus (TMN) and dopaminergic (DA) neurons in the ventral periaqueductal gray (vPAG) (<xref rid="ref53" ref-type="bibr">John et al., 2004</xref>; <xref rid="ref64" ref-type="bibr">Ko et al., 2003</xref>; <xref rid="ref132" ref-type="bibr">Verret et al., 2006</xref>). This pathway receives signals from neurons in the LH, including orexin (ORX) and melanin-concentrating hormone (MCH), and acetylcholine (ACh) and GABA from neurons in the basal forebrain (BF), and leads to cortical activation and wakefulness. The second ascending arousal pathway includes cholinergic neurons in the pedunculopontine tegmental nucleus (PPT) and laterodorsal tegmental nucleus (LDT). Their activation stimulates thalamic relay neurons, resulting in cortical activation and maintenance of conscious wakefulness (<xref rid="ref85" ref-type="bibr">Morin et al., 2015</xref>).</p><p>In addition, the sleep-promoting system includes the hypothalamic ventrolateral preoptic area, basal ganglia, cerebral cortex, limbic system, BF, and the brainstem and thalamus (<xref rid="ref111" ref-type="bibr">Saper et al., 2005</xref>). Activation of GABAergic neurons in the ventrolateral preoptic nucleus (VLPO) and inhibition of NA activity mediated sleep are the core sleep-promoting cluster (<xref rid="ref33" ref-type="bibr">Dubourget et al., 2017</xref>). Moreover, VLPO GABAergic neurons can inhibit the activation of wakefulness systems, including the LDT, dorsal raphe nucleus (DRN), and locus coeruleus (LC), causing a transition to sleep (<xref rid="ref85" ref-type="bibr">Morin et al., 2015</xref>).</p><p>Sleep&#x02013;wake homeostasis is maintained by the &#x0201c;Flip-Flop Switch&#x0201d; model, in which transition between sleep and arousal depends on interactions among the VLPO, monoaminergic cell groups (nuclei) and ORX neurons (<xref rid="ref85" ref-type="bibr">Morin et al., 2015</xref>; <xref rid="ref111" ref-type="bibr">Saper et al., 2005</xref>). Dysregulation of the arousal system, characterized by heightened physiological arousal during both sleep and wakefulness, results in a state known as hyperarousal, which is a significant contributor to insomnia (<xref rid="ref106" ref-type="bibr">Riemann et al., 2010</xref>).</p></sec></sec><sec id="sec5"><label>3</label><title>An association of GABA with anxiety and insomnia</title><p>Insomnia is considered to exacerbate anxiety, since inadequate sleep can increase negative emotions, diminish positive emotions, and alter adolescents&#x02019; comprehension, expression and modulation of emotions (<xref rid="ref9" ref-type="bibr">Blake et al., 2018</xref>; <xref rid="ref96" ref-type="bibr">Palmer and Alfano, 2017</xref>). Conversely, anxiety can contribute to the onset of insomnia, and stress exposure disrupts sleep, leading to difficulties in both falling asleep and staying asleep (<xref rid="ref56" ref-type="bibr">Kalmbach et al., 2018</xref>).</p><p>It appears that both anxiety disorder and insomnia are associated with decreased levels of GABA. Significantly reduced GABA levels have been observed in brains of individuals with anxiety disorders, particularly in the thalamus and the amygdala, as detected by Magnetic Resonance Spectroscopy (MRS) analysis (<xref rid="ref4" ref-type="bibr">Babaev et al., 2018</xref>; <xref rid="ref123" ref-type="bibr">Streeter et al., 2010</xref>). GABA levels in plasma of patients with anxiety have shown notable decreases (<xref rid="ref79" ref-type="bibr">Lydiard, 2003</xref>; <xref rid="ref114" ref-type="bibr">Shutta et al., 2021</xref>). Moreover, reduced expression levels of GABA<sub>A</sub> receptor &#x003b1;1 and &#x003b1;2 subunits have also been detected in the serum of insomnia patients (<xref rid="ref139" ref-type="bibr">Xiang et al., 2023</xref>). On the other hand, the GABA<sub>A</sub> receptor agonist, such as benzodiazepine, can effectively alleviate symptoms of anxiety and treat insomnia, and the antagonist of GABA<sub>B</sub> and GABA<sub>C</sub> receptors, like CGP-36742, can reduce a patient&#x02019;s slow-wave sleep (<xref rid="ref31" ref-type="bibr">Deschaux et al., 2006</xref>; <xref rid="ref92" ref-type="bibr">Nutt, 2005</xref>; <xref rid="ref120" ref-type="bibr">Sternbach, 1978</xref>).</p></sec><sec id="sec6"><label>4</label><title>Synthesis and functions of GABA</title><p>GABA is a prominent neurotransmitter within the brain, and also functions as a regulatory hormone in peripheral organs, which holds significant importance for the human body (<xref rid="ref52" ref-type="bibr">Jin and Korol, 2023</xref>; <xref rid="ref149" ref-type="bibr">Zhang et al., 2021</xref>). GABA, also known as 4-aminobutyric acid, is a compound represented by the chemical formula C&#x02084;H&#x02089;NO&#x02082; (<xref rid="fig1" ref-type="fig">Figure 1A</xref>). It is an amino acid that is widely distributed among vertebrates, plants, and microorganisms (<xref rid="ref112" ref-type="bibr">Sarasa et al., 2020</xref>). In living organisms, GABA is primarily synthesized by glutamate decarboxylase (GAD), an enzyme that uses glutamate (L-Glu) as the raw material in the presence of coenzyme pyridoxal phosphate and protons (<xref rid="fig1" ref-type="fig">Figure 1A</xref>) (<xref rid="ref117" ref-type="bibr">Soghomonian and Martin, 1998</xref>).</p><fig position="float" id="fig1"><label>Figure 1</label><caption><p>Structure and production of GABA. <bold>(A)</bold> The production diagram of GABA. With the assistance of pyridoxal phosphate, the glutamate decarboxylase (GAD) enzyme is transformed into an active structure and then converts L-Glu into GABA. L-Glu, GABA, and Pyridoxal phosphate are illustrated by PubChem. White ball: the hydrogen atom; red ball: the oxygen atom; gray ball: the carbon atom; blue ball: the nitrogen atom; yellow ball: the phosphorus atom. <bold>(B)</bold> The diagram of GABA&#x02019;s production by gut microbiota. The genome of many bacteria carries the gadB and gadC genes. The gadB is a type of GAD in <bold>(A)</bold>, and functions in the same manner as GAD. GABA produced by gadB can be transported extracellularly through gadC. Meanwhile, the raw material L-Glu can also enter the cell through gadC, and this process can consume H<sup>+</sup> ions outside the environment.</p></caption><graphic xlink:href="fnins-19-1570173-g001" position="float"/></fig><p>In bacteria, GABA is primarily involved in the survival ability in an acidic environment. <italic>Escherichia coli</italic> and other enterobacteria utilize the H<sup>+</sup> consuming reaction catalyzed by gad to reduce the concentration of H<sup>+</sup> around the microorganism itself, and survive in the stomach acidity before reaching the intestine (<xref rid="fig1" ref-type="fig">Figure 1B</xref>) (<xref rid="ref112" ref-type="bibr">Sarasa et al., 2020</xref>). In the vertebrates, GABA primarily acts on GABA receptors, triggering ion exchange across the neuronal membrane, altering current signals, and generating inhibitory potentials, thereby inhibiting neuronal excitation (<xref rid="ref126" ref-type="bibr">Taylor et al., 2003</xref>). Particularly, GABA can act on ionotropic receptors such as GABA<sub>A</sub> and GABA<sub>C</sub> receptors, as well as the metabotropic receptor GABA<sub>B</sub> receptor in the brain (<xref rid="fig2" ref-type="fig">Figure 2</xref>) (<xref rid="ref37" ref-type="bibr">Felice et al., 2022</xref>).</p><fig position="float" id="fig2"><label>Figure 2</label><caption><p>Diagram of GABA receptors&#x02019; workflow and GABA&#x02019;s conversion balance. <bold>(A)</bold> GABA<sub>A</sub> receptors&#x02019; workflow and the balance among GABA, glutamine and glutamate. GABA neurons can convert the absorbed glutamine into glutamate, and then into GABA. Subsequently, GABA is excreted and acts on the next neuron. Upon the binding of GABA to the GABA<sub>A</sub> receptor, it prompts the opening of chloride ion channels within the receptor, thereby giving rise to either the inward or outward flow of chloride ions. The predominant direction of movement is the inward flow. <bold>(B)</bold> GABA<sub>B</sub> receptors&#x02019; workflow. GABA<sub>B</sub> receptors are capable of anchoring to Ca<sup>2+</sup> and K<sup>+</sup> channels on the cell membrane. Through the dynamic modulation of the closure of these ion channels, it restricts the influx of Ca<sup>2+</sup> and augments the influx of K<sup>+</sup>, thereby attaining an inhibitory hyperpolarized state of the membrane potential.</p></caption><graphic xlink:href="fnins-19-1570173-g002" position="float"/></fig><p>GABA<sub>A</sub> receptors are pentameric ligand-gated ion channels widely expressed throughout the central and peripheral nervous system (<xref rid="ref78" ref-type="bibr">Luo and Balle, 2022</xref>). When GABA binds to the GABA<sub>A</sub> receptor, it causes the chloride ion channels on the receptor to open, and leads to either the influx or efflux of chloride ions, with the predominant movement being the influx (<xref rid="fig2" ref-type="fig">Figure 2A</xref>) (<xref rid="ref60" ref-type="bibr">Kim and Hibbs, 2021</xref>). The opening of the chloride ion channels by GABA helps stabilize the resting potential of cells during the activation of excitatory receptors and makes it more difficult for neurons to generate excitatory action potentials and release neurotransmitters (<xref rid="ref11" ref-type="bibr">Bormann, 1988</xref>; <xref rid="ref60" ref-type="bibr">Kim and Hibbs, 2021</xref>).</p><p>GABA<sub>B</sub> receptors are G-protein coupled receptors and primarily exist in a heterodimeric form. Different from the GABA<sub>A</sub> ion channels, GABA<sub>B</sub> receptors can anchor to Ca<sup>2+</sup> and K<sup>+</sup> channels on the cell membrane (<xref rid="fig2" ref-type="fig">Figure 2B</xref>) (<xref rid="ref11" ref-type="bibr">Bormann, 1988</xref>). By dynamically regulating the closure of these ion channels, it inhibits the influx of Ca<sup>2+</sup> and promotes the influx of K<sup>+</sup> to achieve an inhibitory hyperpolarized state of the membrane potential. Additionally, it can dynamically regulate the switches of the G-proteins it anchors to, realizing the activation of guanine nucleotide-binding proteins and indirectly producing the second messenger cAMP to exert its effects (<xref rid="ref7" ref-type="bibr">Bettler et al., 2004</xref>).</p><p>The GABA<sub>C</sub> receptor is a subclass of the GABA<sub>A</sub> receptor, and is often referred to as the GABA<sub>A</sub> rho receptor with three different subtypes &#x003c1;1-3 (<xref rid="ref95" ref-type="bibr">Olsen and Sieghart, 2008</xref>). Its structure and function are largely similar to those of GABA<sub>A</sub> receptors. It is categorized separately due to being insensitive to both bicuculline and baclofen (<xref rid="ref54" ref-type="bibr">Johnston, 2013</xref>).</p><p>In the brain, GABA primarily plays a role in intermediate neurons, which are notably rich in the enzyme GAD. Experimental findings have revealed that the removal of the GAD enzyme from the mouse brain tissue results in a significant reduction in detectable GABA levels (<xref rid="ref50" ref-type="bibr">Ji et al., 1999</xref>).</p><p>In the synaptic cleft, any excess GABA that remains unabsorbed after transmission is re-uptaken by astrocytes, where it is converted into glutamine (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). This glutamine is then utilized by glutamatergic neurons to synthesize glutamate. Subsequently, the released glutamate is taken up by GABAergic neurons to regenerate GABA. Through the coordinated activity of glutamatergic neurons, GABAergic neurons and astrocytes, GABA stays at a balanced level, and the neural network maintains a state of equilibrium, which is essential for the proper functioning of the brain (<xref rid="ref82" ref-type="bibr">Mazzoli and Pessione, 2016</xref>; <xref rid="ref119" ref-type="bibr">Steel et al., 2020</xref>).</p><p>In patients with anxiety and insomnia, signs of excessive consumption of GABA were detected. This may be related to the overactivity of GABA transaminase, which causes excessive conversion of GABA into succinic semialdehyde (SSA), reducing the neuroinhibitory effect of GABA (<xref rid="ref74" ref-type="bibr">Liu M. Q. et al., 2022</xref>). Adding some GABA transaminase inhibitors can be effective in the treatment of anxiety and insomnia (<xref rid="ref32" ref-type="bibr">Di Pierro et al., 2024</xref>; <xref rid="ref74" ref-type="bibr">Liu M. Q. et al., 2022</xref>; <xref rid="ref118" ref-type="bibr">Srichomphu et al., 2022</xref>).</p></sec><sec id="sec7"><label>5</label><title>Therapeutic effects of gut derived GABA on anxiety and insomnia</title><sec id="sec8"><label>5.1</label><title>Anxiety</title><p>Gut derived GABA encompasses GABA obtained from dietary sources as well as GABA produced by the resident gut microbiota, and represents a significant source of GABA in the human body (<xref rid="ref34" ref-type="bibr">Duranti et al., 2020</xref>; <xref rid="ref76" ref-type="bibr">Liwinski et al., 2023</xref>). Direct oral GABA supplements and dietary food, for instance potatoes, tomatoes, rice, tea and beans, are primary sources of gut derived GABA (<xref rid="tab1" ref-type="table">Tables 1</xref>, <xref rid="tab2" ref-type="table">2</xref>) (<xref rid="ref21" ref-type="bibr">Cai et al., 2014</xref>; <xref rid="ref45" ref-type="bibr">Hinton and Johnston, 2020</xref>; <xref rid="ref62" ref-type="bibr">Kim et al., 2015</xref>; <xref rid="ref71" ref-type="bibr">Lei et al., 2023</xref>; <xref rid="ref76" ref-type="bibr">Liwinski et al., 2023</xref>; <xref rid="ref131" ref-type="bibr">Vann et al., 2020</xref>; <xref rid="ref142" ref-type="bibr">Yan et al., 2021</xref>). Moreover, bacteria can convert glutamate into GABA through a process that utilizes protons (<xref rid="ref36" ref-type="bibr">Feehily and Karatzas, 2013</xref>). Probiotic bacteria such as <italic>Bifidobacterium</italic>, <italic>Lactobacillus</italic> and <italic>Lactiplantibacillus</italic> can produce GABA and significantly increase the GABA level in the intestines (<xref rid="tab3" ref-type="table">Table 3</xref>) (<xref rid="ref5" ref-type="bibr">Barrett et al., 2012</xref>; <xref rid="ref34" ref-type="bibr">Duranti et al., 2020</xref>; <xref rid="ref77" ref-type="bibr">Luck et al., 2021</xref>; <xref rid="ref136" ref-type="bibr">Watanabe et al., 2022</xref>). Notably, studies have shown that gut derived GABA can treat anxiety and insomnia by exerting a widespread influence on hormone levels, secretion of signaling molecules, gene expression, and various other physiological changes (<xref rid="ref2" ref-type="bibr">Abdou et al., 2006</xref>; <xref rid="ref76" ref-type="bibr">Liwinski et al., 2023</xref>; <xref rid="ref140" ref-type="bibr">Yamatsu et al., 2015</xref>).</p><table-wrap position="float" id="tab1"><label>Table 1</label><caption><p>Gut derived GABA exhibits therapeutic effects in the treatment of anxiety.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Subject</th><th align="center" valign="top" rowspan="1" colspan="1">Dosing</th><th align="center" valign="top" rowspan="1" colspan="1">Frequency</th><th align="center" valign="top" rowspan="1" colspan="1">Function</th><th align="center" valign="top" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Human</td><td align="center" valign="top" rowspan="1" colspan="1">100&#x0202f;mg</td><td align="center" valign="top" rowspan="1" colspan="1">3 administrations, separated by 7-day intervals</td><td align="center" valign="top" rowspan="1" colspan="1">Anxiety &#x02193;, Brain alpha wave &#x02191;, beta wave &#x02193;, saliva IgA level &#x02191;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref2" ref-type="bibr">Abdou et al. (2006)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Human</td><td align="center" valign="top" rowspan="1" colspan="1">100&#x0202f;mg</td><td align="center" valign="top" rowspan="1" colspan="1">Everyday for 8&#x0202f;weeks</td><td align="center" valign="top" rowspan="1" colspan="1">Stress &#x02193;, Alpha &#x00026; beta band brain waves &#x02193;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref144" ref-type="bibr">Yoto et al. (2012)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Human</td><td align="center" valign="top" rowspan="1" colspan="1">0&#x02013;50&#x0202f;mg (beverage)</td><td align="center" valign="top" rowspan="1" colspan="1">Once a time</td><td align="center" valign="top" rowspan="1" colspan="1">Psychological fatigue &#x02193;, Salivary chromogranin A &#x00026; cortisol levels &#x02193;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref58" ref-type="bibr">Kanehira et al. (2011)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Human</td><td align="center" valign="top" rowspan="1" colspan="1">28&#x0202f;mg GABA (chocolate)</td><td align="center" valign="top" rowspan="1" colspan="1">Once a time</td><td align="center" valign="top" rowspan="1" colspan="1">Psychological stress &#x02193;, HRV (heart rate variability) &#x02191;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref90" ref-type="bibr">Nakamura et al. (2009)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Human</td><td align="center" valign="top" rowspan="1" colspan="1">Vegetable tablets containing GABA</td><td align="center" valign="top" rowspan="1" colspan="1">Once a time</td><td align="center" valign="top" rowspan="1" colspan="1">Sympathetic nervous activity &#x02193;, blood pressure &#x02191;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref94" ref-type="bibr">Okita et al. (2009)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Human</td><td align="center" valign="top" rowspan="1" colspan="1">GABA-fortified oolong tea</td><td align="center" valign="top" rowspan="1" colspan="1">Once a time</td><td align="center" valign="top" rowspan="1" colspan="1">Chronic stress &#x02193;, autonomic imbalance impact &#x02193;, HRV &#x02191;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref44" ref-type="bibr">Hinton et al. (2019)</xref>
</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tab2"><label>Table 2</label><caption><p>Gut derived GABA exhibits therapeutic effects in the treatment of insomnia.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Subject</th><th align="center" valign="top" rowspan="1" colspan="1">Dosing</th><th align="center" valign="top" rowspan="1" colspan="1">Dosing frequency</th><th align="center" valign="top" rowspan="1" colspan="1">Function</th><th align="center" valign="top" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Human</td><td align="center" valign="top" rowspan="1" colspan="1">300&#x0202f;mg</td><td align="center" valign="top" rowspan="1" colspan="1">Everyday for 4&#x0202f;weeks</td><td align="center" valign="top" rowspan="1" colspan="1">Sleep latency &#x02193;, sleep efficacy &#x02191;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref20" ref-type="bibr">Byun et al. (2018)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Human</td><td align="center" valign="top" rowspan="1" colspan="1">100&#x0202f;mg</td><td align="center" valign="top" rowspan="1" colspan="1">30&#x0202f;min before going to bed, everyday</td><td align="center" valign="top" rowspan="1" colspan="1">Sleep latency &#x02193;, NREM sleep &#x02191;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref140" ref-type="bibr">Yamatsu et al. (2015)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Human</td><td align="center" valign="top" rowspan="1" colspan="1">100&#x0202f;mg</td><td align="center" valign="top" rowspan="1" colspan="1">Every day for a week</td><td align="center" valign="top" rowspan="1" colspan="1">Plasma GABA levels &#x02191;, sleep latency &#x02193;, total non-REM sleep duration &#x02191;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref141" ref-type="bibr">Yamatsu et al. (2016)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Human</td><td align="center" valign="top" rowspan="1" colspan="1">GABA tea</td><td align="center" valign="top" rowspan="1" colspan="1">Everyday for a month</td><td align="center" valign="top" rowspan="1" colspan="1">Sleep onset latency &#x02193;, REM onset latency &#x02191;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref29" ref-type="bibr">Cheng and Tsai (2009)</xref>
</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tab3"><label>Table 3</label><caption><p>Summary of bacterial strains producing GABA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Subject</th><th align="center" valign="top" rowspan="1" colspan="1">Strain</th><th align="center" valign="top" rowspan="1" colspan="1">Function</th><th align="center" valign="top" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Human</td><td align="center" valign="top" rowspan="1" colspan="1">
<italic>Bifidobacterium breve M-16V</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">Mood and sleep scores &#x02191;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref88" ref-type="bibr">Mutoh et al. (2024)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Human</td><td align="center" valign="top" rowspan="1" colspan="1">
<italic>Lactobacillus brevis DPC6108</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">Gut GABA capacity &#x02191;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref5" ref-type="bibr">Barrett et al. (2012)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mice</td><td align="center" valign="top" rowspan="1" colspan="1">
<italic>Bifidobacterium adolescentis IM38</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">Anti-anxiolytic-like effect &#x02191;, Corticosterone and IL-6 blood levels &#x02193;, Blood TNF-&#x003b1; level &#x02193;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref48" ref-type="bibr">Jang et al. (2018)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mice</td><td align="center" valign="top" rowspan="1" colspan="1">
<italic>Bifidobacterium longum DD98</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">Depression and anxiety-like behaviors &#x02193;, Serotonin, GABA, NPY, BDNF expression &#x02191;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref51" ref-type="bibr">Jin et al. (2023)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mice</td><td align="center" valign="top" rowspan="1" colspan="1">
<italic>Lactobacillus rhamnosus (JB-1)</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">Anxiety and depression-related behaviors &#x02193;, GABA<sub>A,B</sub> receptors sub-types in specific brain regions &#x02191;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref49" ref-type="bibr">Janik et al. (2016)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mice</td><td align="center" valign="top" rowspan="1" colspan="1">
<italic>Lactobacillus plantarum 286 and 81</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">Anti-depressant-like and anxiolytic-like effects &#x02191;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref6" ref-type="bibr">Barros-Santos et al. (2020)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mice</td><td align="center" valign="top" rowspan="1" colspan="1">
<italic>Lactobacillus plantarum HJZW08</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">Anxiety-like and depressive-like behaviors &#x02193;, neuroactive molecules levels &#x02191;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref138" ref-type="bibr">Wu et al. (2022)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mice</td><td align="center" valign="top" rowspan="1" colspan="1">
<italic>Lactobacillus rhamnosus GG</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">Anxiety behaviors &#x02193;, BDNF and GABA receptors levels in hippocampus and amygdala &#x02191;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref152" ref-type="bibr">Zhou B. et al. (2022)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mice</td><td align="center" valign="top" rowspan="1" colspan="1">
<italic>Lactiplantibacillus plantarum LZU-J-TSL6</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">Anxiety disorder &#x02193;, hippocampal region GABA content &#x02191;, some anxiety-related markers &#x02191;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref73" ref-type="bibr">Liu G. et al. (2022)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mice</td><td align="center" valign="top" rowspan="1" colspan="1">
<italic>Lacticaseibacillus rhamnosus GG</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">Anxiety and depressive-like phenotype &#x02193;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref35" ref-type="bibr">Faucher et al. (2022)</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Monkey</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>Bifid Triple Viable Capsules</italic> (<italic>Bifidobacterium</italic>, <italic>Lactobacillus</italic>, and <italic>Enterococcus faecalis</italic>.)</td><td align="center" valign="top" rowspan="1" colspan="1">Plasma GABA levels &#x02191;, stress responses and gut microbiota dysbiosis &#x02193;</td><td align="center" valign="top" rowspan="1" colspan="1">
<xref rid="ref151" ref-type="bibr">Zhao et al. (2022)</xref>
</td></tr></tbody></table></table-wrap><p>Studies indicate that both the direct administration of 100&#x0202f;mg of GABA and the consumption of GABA-containing foods exhibit a certain therapeutic effect on anxiety-related behaviors (<xref rid="tab1" ref-type="table">Table 1</xref>) (<xref rid="ref6" ref-type="bibr">Barros-Santos et al., 2020</xref>; <xref rid="ref35" ref-type="bibr">Faucher et al., 2022</xref>; <xref rid="ref144" ref-type="bibr">Yoto et al., 2012</xref>). The administration of the GABA-producing strain <italic>Bifidobacterium adolescentis IM38</italic> significantly improved anxiety-like behaviors in mice, and this effect was blocked by flumazenil, a benzodiazepine receptor antagonist (<xref rid="ref48" ref-type="bibr">Jang et al., 2018</xref>). This finding suggests that gut derived GABA exerts their influence through GABA-regulated sites, potentially acting on GABA receptors in the brain. Moreover, administering probiotics <italic>Lactiplantibacillus plantarum SNK12</italic>, which produces GABA, has been shown to alleviate anxiety and reduce salivary cortisol levels in humans (<xref rid="ref136" ref-type="bibr">Watanabe et al., 2022</xref>). Similar phenomena are also observed in animal models (<xref rid="ref22" ref-type="bibr">Cai et al., 2022</xref>).</p></sec><sec id="sec9"><label>5.2</label><title>Insomnia</title><p>Clinical trials have provided evidence that the administration of 100&#x0202f;mg of GABA significantly improves sleep quality, which is reflected by a reduction in sleep latency and an increase in the duration of non-REM sleep (<xref rid="tab2" ref-type="table">Table 2</xref>) (<xref rid="ref140" ref-type="bibr">Yamatsu et al., 2015</xref>; <xref rid="ref141" ref-type="bibr">Yamatsu et al., 2016</xref>). Similar positive effects on sleep quality have been observed in clinical trials involving the consumption of GABA tea (<xref rid="ref29" ref-type="bibr">Cheng and Tsai, 2009</xref>). In animal studies, a significant decrease in peripheral blood GABA concentration of sleep-deprived monkeys, accompanied by a substantial increase in peripheral blood NE and cortisol, both indicative of HPA axis upregulation (<xref rid="ref151" ref-type="bibr">Zhao et al., 2022</xref>). Supplementation with probiotics producing GABA significantly reduced the levels of hormones associated with the HPA axis and increased peripheral blood GABA levels, suggesting a therapeutic effect. Similar findings were also reported in mouse experiments. Mice fed GABA black tea exhibited a significant decrease in sleep latency period induced by pentobarbital sodium, accompanied by a substantial increase in the duration of effective sleep (<xref rid="ref150" ref-type="bibr">Zhao et al., 2015</xref>). Administration of 100&#x0202f;mg/kg GABA not only significantly reduced sleep latency and increased sleep duration, but also elevated the expression levels of GABA receptor mRNA in the mouse brain, proving that supplementing with gut derived GABA can indeed enhance GABAergic signaling in the brain and improve sleep (<xref rid="ref28" ref-type="bibr">Chen et al., 2021</xref>; <xref rid="ref61" ref-type="bibr">Kim et al., 2019</xref>; <xref rid="ref75" ref-type="bibr">Liu D. et al., 2022</xref>).</p></sec><sec id="sec10"><label>5.3</label><title>Dosage and side effects</title><p>Studies indicated that a direct administration of 100&#x0202f;mg of GABA represents an appropriate dosage for the treatment of anxiety and insomnia. This dosage can exert positive effects in terms of alleviating anxiety, shortening sleep latency, and enhancing sleep quality (<xref rid="ref2" ref-type="bibr">Abdou et al., 2006</xref>; <xref rid="ref140" ref-type="bibr">Yamatsu et al., 2015</xref>; <xref rid="ref141" ref-type="bibr">Yamatsu et al., 2016</xref>; <xref rid="ref144" ref-type="bibr">Yoto et al., 2012</xref>). Research has demonstrated that even when a relatively high dose, such as 6&#x0202f;g of GABA per day, is administered, no obvious side effects are observed in volunteers, suggesting the favorable biosafety of GABA (<xref rid="ref72" ref-type="bibr">Li et al., 2015</xref>). However, it is noteworthy that current studies have revealed that GABA is not conducive to the anti-tumor response. Multiple investigations have elucidated that GABA can inhibit dendritic cell mediated T-cell recruitment and activation (<xref rid="ref46" ref-type="bibr">Huang et al., 2022</xref>; <xref rid="ref149" ref-type="bibr">Zhang et al., 2021</xref>). Therefore, it is not advisable to use gut derived GABA as a drug treatment for cancer patients.</p></sec><sec id="sec11"><label>5.4</label><title>Probiotics and engineered bacteria</title><p>It is worth noting that in addition to the dietary and orally administered GABA presented in <xref rid="tab1" ref-type="table">Tables 1</xref>, <xref rid="tab2" ref-type="table">2</xref>, the utilization of GABA-producing bacteria has emerged as an innovative therapeutic strategy for anxiety and insomnia (<xref rid="tab3" ref-type="table">Table 3</xref>). A substantial body of research demonstrates that GABA-producing bacteria can effectively mitigate these disorders. These bacteria exert diverse effects on the body, such as diminishing stress factor levels, augmenting GABA concentrations, and modulating the levels of GABA receptors and their corresponding mRNAs in the brain (<xref rid="ref49" ref-type="bibr">Janik et al., 2016</xref>; <xref rid="ref51" ref-type="bibr">Jin et al., 2023</xref>; <xref rid="ref73" ref-type="bibr">Liu G. et al., 2022</xref>; <xref rid="ref152" ref-type="bibr">Zhou B. et al., 2022</xref>).</p><p>Unlike orally ingested GABA, which is rapidly eliminated from the body, GABA-producing gut bacteria can colonize the host&#x02019;s gastrointestinal tract for an extended period. This persistent colonization enables continuous GABA synthesis, thereby conferring prolonged therapeutic benefits (<xref rid="ref102" ref-type="bibr">Pokusaeva et al., 2017</xref>). Additionally, the impact of these bacteria on the gut&#x02019;s ecological environment is persistent over time. Significantly, the employment of probiotic strains has the significant advantage of imposing a lower metabolic burden on organs such as the liver compared to traditional small molecule drugs (<xref rid="ref72" ref-type="bibr">Li et al., 2015</xref>; <xref rid="ref93" ref-type="bibr">Oketch-Rabah et al., 2021</xref>).</p><p>Moreover, through microbiome sequencing, it has been found that some bacteria can either promote or inhibit the growth of GABA-producing bacteria. Supplementation with <italic>Limosilactobacillus fermentum L18</italic> can significantly increase the abundance of <italic>Bifidobacterium</italic> and <italic>Lactobacillus</italic> (<xref rid="ref59" ref-type="bibr">Kaur et al., 2023</xref>). This might be due to that these strains can optimize the acidic environment for GABA production by regulating the intestinal pH value and metabolite exchange. However, some strains, such as <italic>Enterobacteriaceae</italic>, can reduce the abundance of GABA-producing bacteria. This could be due to the production of substances like lipopolysaccharides by these strains, which hinder the growth of GABA-producing bacteria (<xref rid="ref147" ref-type="bibr">Zeng et al., 2024</xref>). Thus, the supplementation of GABA-producing bacteria is still an effective method. In the future, the administration of combined bacterial agents could be considered (<xref rid="ref151" ref-type="bibr">Zhao et al., 2022</xref>).</p><p>Apart from certain natural probiotic strains like <italic>Bifidobacterium</italic> and <italic>Lactobacillus</italic>, genetically engineered bacterial strains have also been harnessed in the treatment of anxiety. To date, numerous studies have endeavored to employ engineered probiotics to express GABA and address anxiety (<xref rid="ref68" ref-type="bibr">Lebovich and Andrews, 2022</xref>, <xref rid="ref69" ref-type="bibr">2023</xref>; <xref rid="ref98" ref-type="bibr">Pan et al., 2022</xref>; <xref rid="ref102" ref-type="bibr">Pokusaeva et al., 2017</xref>). The advantage of using engineered bacteria for anxiety treatment resides in the precise regulation of GABA production, for instance treating anxious mice using an engineered <italic>Lactococcus lactis</italic> strain (<xref rid="ref98" ref-type="bibr">Pan et al., 2022</xref>).</p><p>Moreover, the majority of these studies have adopted <italic>Escherichia coli Nissle 1917</italic> (<italic>EcN</italic>) (<xref rid="ref68" ref-type="bibr">Lebovich and Andrews, 2022</xref>, <xref rid="ref69" ref-type="bibr">2023</xref>). <italic>EcN</italic> is a renowned probiotic strain of <italic>Escherichia coli</italic>. Owing to its probiotic properties and well-defined manipulable genetic background, it is currently extensively utilized as a vector in engineered bacteria therapy (<xref rid="ref80" ref-type="bibr">Lynch et al., 2022</xref>). When engineered <italic>EcN</italic> is employed to produce GABA, the GABA yield can attain as high as 17.9&#x0202f;g/L (<xref rid="ref67" ref-type="bibr">Lan et al., 2021</xref>). Another benefit of engineered bacteria is their proficiency in GABA production, as they can overexpress gadB and gadC proteins within the bacteria. Nevertheless, at present, research articles on the application of <italic>EcN</italic> that produces GABA to treat neurological diseases remain relatively scarce, presenting an area worthy of future exploration.</p><p>There are several issues regarding probiotics that need to be addressed. The introduction of gut microbiota can alter intestinal metabolic activities in the host, which may have adverse effects on a very small number of individuals. For example, the probiotics <italic>L. acidophilus</italic> and <italic>Bifidobacterium</italic> can convert primary bile salts into secondary bile salts (<xref rid="ref109" ref-type="bibr">Ruseler-van Embden et al., 1995</xref>). Most secondary bile salts are reabsorbed to enter the liver for metabolism. If the liver function is abnormal and unable to metabolize secondary bile salts properly, it may lead to their accumulation in the liver, exerting toxic effects on liver cells and further aggravating liver damage (<xref rid="ref146" ref-type="bibr">Zawistowska-Rojek and Tyski, 2018</xref>). Moreover, some probiotics may carry antibiotic-resistance genes, which poses a risk of potential transfer of these genes within the gut microbiota (<xref rid="ref83" ref-type="bibr">Merenstein et al., 2023</xref>). These issues need to be considered and addressed in the future studies.</p></sec><sec id="sec12"><label>5.5</label><title>Gut microbiota</title><p>To optimize the application of gut derived GABA, it is crucial to summarize and investigate the underlying mechanisms of its effects. When GABA is taken orally and enters the intestinal tract, it will first be affected by the body&#x02019;s intestinal microbiota (<xref rid="fig3" ref-type="fig">Figure 3</xref>). GABA is reported to act as a critical growth factor for certain strains of intestinal bacteria in the human gut microbiota, leading to an increase of these specific microbial communities within the host (<xref rid="ref122" ref-type="bibr">Strandwitz et al., 2019</xref>). GABA also serves as a carbon and nitrogen source for the gut microbiota. Within bacteria, GABA can be further converted into succinic semialdehyde (SSA) by GABA transaminase. Subsequently, SSA is transformed into succinate by the enzyme succinic semialdehyde dehydrogenase, which then enters the tricarboxylic acid (TCA) cycle for further metabolic processing (<xref rid="ref112" ref-type="bibr">Sarasa et al., 2020</xref>).</p><fig position="float" id="fig3"><label>Figure 3</label><caption><p>The mechanism of gut derived GABA on human body. Two sources gut derived GABA: one is obtained through direct oral intake or via food, and the other is generated by the gut microbiota. Subsequently, GABA will directly act on the gut microbiota and have a direct impact on its metabolism. A significant portion will also be absorbed by the gut, enter the bloodstream, or act on enteric neurons and the vagus nerve. GABA that acts on the enteric nerves and vagus nerve can be transmitted through neural signals and affect the brain. GABA that enters the bloodstream may eventually interact with the brain by crossing the blood&#x02013;brain barrier.</p></caption><graphic xlink:href="fnins-19-1570173-g003" position="float"/></fig></sec><sec id="sec13"><label>5.6</label><title>GABA absorption</title><sec id="sec14"><label>5.6.1</label><title>Small intestine epithelial cell transport: SLC family</title><p>The initial site of interaction between gut derived GABA and the human body is the intestinal tract. In the intestine, gut derived GABA is absorbed by intestine epithelial cells (<xref rid="fig4" ref-type="fig">Figure 4</xref>). The intestine normally employs passive absorption to transport small-molecule substances, such as amino acids (<xref rid="ref89" ref-type="bibr">N&#x000e1;cher et al., 1994</xref>; <xref rid="ref127" ref-type="bibr">Thwaites et al., 2000</xref>). GABA transporters in the intestines of both rodents and humans facilitate both active and passive absorption of GABA (<xref rid="ref89" ref-type="bibr">N&#x000e1;cher et al., 1994</xref>; <xref rid="ref127" ref-type="bibr">Thwaites et al., 2000</xref>). Proton-coupled amino acid transporter 1 (PAT1) has been confirmed as the GABA transporter responsible for transporting GABA across the apical membrane of intestinal epithelial cells into the cells (<xref rid="fig4" ref-type="fig">Figure 4B</xref>) (<xref rid="ref27" ref-type="bibr">Chen et al., 2003</xref>).</p><fig position="float" id="fig4"><label>Figure 4</label><caption><p>Exogenous GABA intestinal absorption pathway. <bold>(A)</bold> GABA intestinal absorption diagram: Initially, GABA is taken up by intestinal epithelial cells. Then, it diverges into three pathways: bloodstream entry, interaction with enteric neurons, and connection with the vagus nerve. <bold>(B)</bold> GABA intestinal transport: GABA crosses the small intestine membrane via the PAT protein on the basolateral side and exits through a probable SLC family protein on the apical side. <bold>(C)</bold> GABA integrates into the blood circulation: GABA penetrates the fenestrated capillaries within the intestinal lining to join the bloodstream. <bold>(D)</bold> GABA binds to receptors: GABA interacts with GABA receptors on intestinal neurons and the vagus nerve, as previously described, to exert its effects.</p></caption><graphic xlink:href="fnins-19-1570173-g004" position="float"/></fig><p>It is speculated that small intestinal epithelial cells exclude GABA from the basal membrane into the extracellular space of the submucosal layer through one of the solute carrier transporters (SLC) family proteins (<xref rid="fig4" ref-type="fig">Figure 4B</xref>). SLC transporters comprise approximately 350 members belonging to 55 families, with some SLC proteins exhibit bidirectional transport functions (<xref rid="ref66" ref-type="bibr">Kristensen et al., 2011</xref>). For example, SLC6A1 (GAT1) mediates the transport of GABA together with sodium and chloride ions, and is responsible for the reuptake of GABA from the synapse. The direction and magnitude of GABA transport are determined by thermodynamic conditions, influenced by factors such as membrane potential and the concentrations of Na<sup>+</sup>, Cl<sup>&#x02212;</sup>, and GABA (<xref rid="ref81" ref-type="bibr">Mattison et al., 2018</xref>). SLC family proteins with bidirectional transport mechanisms or one that transports GABA from intracellular to extracellular spaces may exist at the basal membrane of small intestinal epithelial cells, facilitating the transport of GABA (<xref rid="ref145" ref-type="bibr">Zafar and Jabeen, 2018</xref>). Further research is necessary to confirm this possibility.</p></sec><sec id="sec15"><label>5.6.2</label><title>Capillary absorption</title><p>When GABA is transported by small intestinal epithelial cells to the lamina propria, it partially enters the capillaries to participate in blood circulation (<xref rid="fig4" ref-type="fig">Figure 4C</xref>). The capillaries in the lamina propria are fenestrated, called &#x0201c;fenestrated capillary,&#x0201d; meaning that they have intracellular pores or &#x0201c;windows&#x0201d; with a diaphragm that penetrate the endothelial lining (<xref rid="ref3" ref-type="bibr">Augustin and Koh, 2017</xref>). These pores facilitate the exchange of water and allow the passage of solutes, such as small peptides, between plasma and interstitial fluid. Fenestrated capillaries are found throughout various tissues, including the choroid plexus of the brain, certain endocrine organs, kidney filtration sites, and intestinal absorptive regions (<xref rid="ref3" ref-type="bibr">Augustin and Koh, 2017</xref>). Given that GABA is significantly smaller than peptides, it can theoretically pass through the pores of fenestrated capillaries. Consequently, research has demonstrated that GABA derived from the gut can effectively elevate GABA levels in the bloodstream of both humans and animal models (<xref rid="ref141" ref-type="bibr">Yamatsu et al., 2016</xref>; <xref rid="ref151" ref-type="bibr">Zhao et al., 2022</xref>).</p></sec><sec id="sec16"><label>5.6.3</label><title>Vagus nerve absorption</title><p>GABA is transported by small intestinal epithelial cells to the lamina propria, where some enter the bloodstream, and some act on the intestinal nerve plexus, which causes intestinal muscles and glands to respond and transmit signals to other parts such as the brain through the vagus nerve (<xref rid="fig4" ref-type="fig">Figure 4D</xref>). Interestingly, administering <italic>Lactobacillus rhamnosus (JB-1)</italic>, a probiotic strain producing GABA, has been shown to improve anxiety-and depression-related behaviors in mice (<xref rid="ref14" ref-type="bibr">Bravo et al., 2011</xref>). However, after surgically removing the vagus nerves in mice fed with the probiotic, the behavioral improvements were lost, indicating that the vagus nerve serves as a major modulatory constitutive communication pathway between gut-exposed bacteria and the brain.</p></sec><sec id="sec17"><label>5.6.4</label><title>Hypothalamus&#x02014;hormone secretion</title><p>After receiving the signals of gut derived GABA, the afferent fibers of the vagus nerve in the gastrointestinal tract transmit the messages through neuronal synapses, converting them into cholinergic signals (<xref rid="ref103" ref-type="bibr">Qu et al., 2024</xref>). These signals are then transmitted to the nucleus tractus solitarius (NTS) in the medulla oblongata. Subsequently, the NTS communicates with the locus coeruleus, which sends signals onward to either the amygdala or the thalamus (<xref rid="ref15" ref-type="bibr">Breit et al., 2018</xref>). Additionally, the hypothalamus directly receives signals from GABA in the peripheral blood. Structurally, it is closely connected to the primary capillary plexus within the pituitary portal system (<xref rid="ref47" ref-type="bibr">Ilgin, 2020</xref>). Studies have shown that injecting competitive antagonists of GABA<sub>A</sub> receptors into the PVN significantly increases stress-induced cortisol secretion, whereas selective GABA receptor antagonists notably reduce it (<xref rid="ref30" ref-type="bibr">Cullinan et al., 2008</xref>). Moreover, supplementation with GABA-producing probiotics inhibits the activated HPA axis. Indeed, this indirectly provides evidence that GABA in peripheral blood can act on the hypothalamus to regulate the HPA axis (<xref rid="ref22" ref-type="bibr">Cai et al., 2022</xref>; <xref rid="ref136" ref-type="bibr">Watanabe et al., 2022</xref>).</p></sec></sec><sec id="sec18"><label>5.7</label><title>Brain</title><sec id="sec19"><label>5.7.1</label><title>The pathway of gut derived GABA entering the brain</title><p>The impact of gut derived GABA on the brain has been a contentious topic, with a central question being the permeability of the blood&#x02013;brain barrier (BBB). While some studies suggest that GABA cannot penetrate the BBB in mammals, other research indicates that GABA can traverse it, albeit in modest quantities (<xref rid="ref10" ref-type="bibr">Boonstra et al., 2015</xref>; <xref rid="ref38" ref-type="bibr">Frey and L&#x000f6;scher, 1980</xref>; <xref rid="ref63" ref-type="bibr">Knudsen et al., 1988</xref>; <xref rid="ref128" ref-type="bibr">Toth and Lajtha, 1981</xref>; <xref rid="ref129" ref-type="bibr">Van Gelder and Elliott, 1958</xref>). Analyzing the structural aspects of the BBB could provide a theoretical basis to support the potential passage of GABA through this barrier.</p><p>The BBB consists of adjacent capillary endothelial cells interconnected by impermeable tight junctions, requiring molecules to enter through active uptake by specialized transporter proteins or by diffusing into the BBB cells (<xref rid="ref1" ref-type="bibr">Abbott et al., 2010</xref>; <xref rid="ref16" ref-type="bibr">Brightman and Reese, 1969</xref>; <xref rid="ref99" ref-type="bibr">Pardridge, 2005</xref>, <xref rid="ref100" ref-type="bibr">2007</xref>). Among these transporters, a crucial group is the SLC6 family, one of the largest SLC families comprising 20 genes that encode highly similar transporter proteins. The SLC6 family, abundantly expressed in the brain, includes GABA transporters such as GAT1 (SLC6A1), GAT2 (SLC6A13), GAT3 (SLC6A11), and BGT1 (SLC6A12). These transporters are responsible for the transport of neurotransmitters into and out of the brain, thereby regulating neurotransmitter homeostasis (<xref rid="ref1" ref-type="bibr">Abbott et al., 2010</xref>). Studies have shown that GAT2/BGT-1 expressed in epithelial cells serve as GABA transporters at the BBB to transport GABA (<xref rid="ref125" ref-type="bibr">Takanaga et al., 2001</xref>). In addition, GAT2/BGT-1 has been found to be widely expressed in the mouse brain. Notably, GAT2 is expressed on both the apical and basal membranes of epithelial cells, exhibiting bidirectional transport capability. In contrast, BGT1 is expressed solely on the basal membrane. GAT2 at the BBB facilitates the transport of GABA.</p><p>Extensive studies have observed increased concentrations of brain GABA and mRNA expression levels of GABA receptors following administration of gut derived GABA (<xref rid="ref51" ref-type="bibr">Jin et al., 2023</xref>; <xref rid="ref136" ref-type="bibr">Watanabe et al., 2022</xref>; <xref rid="ref153" ref-type="bibr">Zhou H. et al., 2022</xref>). These findings collectively support that gut derived GABA can modulate the brain&#x02019;s GABAergic system, potentially alleviating neurological disorders by enhancing GABAergic signaling in the brain.</p></sec></sec></sec><sec id="sec20"><label>6</label><title>Future direction</title><p>Currently, a large portion of the global population is suffering from anxiety and insomnia, grappling with the challenges posed by these mental health disorders. The current sedatives and sleep aids available for treating anxiety and insomnia often come with side effects like physical dependence and withdrawal symptoms (<xref rid="ref115" ref-type="bibr">Shyken et al., 2019</xref>). Hence, the development of novel interventions that address anxiety and insomnia without such drawbacks remains necessary.</p><p>GABA, as a natural neurotransmitter in the human body, poses minimal harm even in high doses (<xref rid="ref72" ref-type="bibr">Li et al., 2015</xref>). The supplementation of GABA through gut derived sources holds great promise. Oral GABA, GABA-enriched diets, and probiotic strains producing GABA have demonstrated positive and effective outcomes in treating anxiety and insomnia. However, oral GABA has several limitations, which include: First, low blood&#x02013;brain barrier permeability: Unlike benzodiazepines, GABA does not efficiently cross the blood&#x02013;brain barrier, limiting its ability to exert strong pharmacological effects. Overall, the efficiency of GABA crossing the blood&#x02013;brain barrier is not very high. Second, low bioavailability: The bioavailability of GABA when ingested is relatively low, and it is quickly eliminated from the body, which makes it challenging to sustain therapeutic efficacy. Third, non-specific effects: GABA is widely distributed throughout the body, not only in the central nervous system but also in many other tissues and organs. This wide distribution may lead to non-specific effects rather than targeting specific diseases or symptoms. An increasing amount of research has found that GABA functions as a signal molecule in the immune system. Several studies have clarified that GABA is not beneficial for the anti-tumor response. So, it is not recommended to provide gut derived GABA as a drug treatment for cancer patients.</p><p>Probiotic and engineered bacteria capable of producing GABA present promising avenues for the treatment of anxiety and insomnia. These bacteria can colonize in the human gut and release GABA promptly. There remain several aspects that warrant further exploration. For instance, determining the optimal drug dosage of probiotics for human treatment and, notably, laying particular emphasis on considering the safety of engineered foreign genes. Future research efforts should be intensified to not only optimize the drug dosage regimens but also to conduct rigorous and systematic investigations into the safety of foreign genes. Only through such meticulous exploration can we hope to translate these promising approaches into reliable and effective therapeutic solutions, thereby offering a new ray of hope for the countless individuals suffering from anxiety and insomnia, and revolutionizing the landscape of mental health treatment.</p></sec></body><back><ack><p>We thank members of the Sun laboratory and members of GeneYoung Biopharmaceuticals for their valuable discussions and advice.</p></ack><sec sec-type="author-contributions" id="sec21"><title>Author contributions</title><p>CJ: Conceptualization, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. YC: Writing &#x02013; review &#x00026; editing. TS: Conceptualization, Investigation, Project administration, Supervision, Writing &#x02013; review &#x00026; editing.</p></sec><sec sec-type="COI-statement" id="sec23"><title>Conflict of interest</title><p>YC is employed by GeneYoung Biopharmaceuticals.</p><p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="sec24"><title>Generative AI statement</title><p>The authors declare that Gen AI was used in the creation of this manuscript. Chengji Jiang polished the paper with ChatGPT.</p></sec><sec sec-type="disclaimer" id="sec25"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbott</surname><given-names>N. J.</given-names></name><name><surname>Patabendige</surname><given-names>A. A.</given-names></name><name><surname>Dolman</surname><given-names>D. E.</given-names></name><name><surname>Yusof</surname><given-names>S. R.</given-names></name><name><surname>Begley</surname><given-names>D. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Structure and function of the blood-brain barrier</article-title>. <source>Neurobiol. Dis.</source>
<volume>37</volume>, <fpage>13</fpage>&#x02013;<lpage>25</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.nbd.2009.07.030</pub-id>, PMID: <pub-id pub-id-type="pmid">19664713</pub-id>
</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdou</surname><given-names>A. M.</given-names></name><name><surname>Higashiguchi</surname><given-names>S.</given-names></name><name><surname>Horie</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name><name><surname>Hatta</surname><given-names>H.</given-names></name><name><surname>Yokogoshi</surname><given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans</article-title>. <source>Biofactors</source>
<volume>26</volume>, <fpage>201</fpage>&#x02013;<lpage>208</lpage>. doi: <pub-id pub-id-type="doi">10.1002/biof.5520260305</pub-id>, PMID: <pub-id pub-id-type="pmid">16971751</pub-id>
</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Augustin</surname><given-names>H. G.</given-names></name><name><surname>Koh</surname><given-names>G. Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Organotypic vasculature: from descriptive heterogeneity to functional pathophysiology</article-title>. <source>Science</source>
<volume>357</volume>:<fpage>eaal2379</fpage>. doi: <pub-id pub-id-type="doi">10.1126/science.aal2379</pub-id>, PMID: <pub-id pub-id-type="pmid">28775214</pub-id>
</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babaev</surname><given-names>O.</given-names></name><name><surname>Piletti Chatain</surname><given-names>C.</given-names></name><name><surname>Krueger-Burg</surname><given-names>D.</given-names></name></person-group> (<year>2018</year>). <article-title>Inhibition in the amygdala anxiety circuitry</article-title>. <source>Exp. Mol. Med.</source>
<volume>50</volume>, <fpage>1</fpage>&#x02013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s12276-018-0063-8</pub-id>, PMID: <pub-id pub-id-type="pmid">29628509</pub-id>
</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>E.</given-names></name><name><surname>Ross</surname><given-names>R. P.</given-names></name><name><surname>O'Toole</surname><given-names>P. W.</given-names></name><name><surname>Fitzgerald</surname><given-names>G. F.</given-names></name><name><surname>Stanton</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>&#x003b3;-Aminobutyric acid production by culturable bacteria from the human intestine</article-title>. <source>J. Appl. Microbiol.</source>
<volume>113</volume>, <fpage>411</fpage>&#x02013;<lpage>417</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2672.2012.05344.x</pub-id>, PMID: <pub-id pub-id-type="pmid">22612585</pub-id>
</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barros-Santos</surname><given-names>T.</given-names></name><name><surname>Silva</surname><given-names>K. S. O.</given-names></name><name><surname>Libarino-Santos</surname><given-names>M.</given-names></name><name><surname>Elisangela Gouveia</surname><given-names>C.-P.</given-names></name><name><surname>Reis</surname><given-names>H. S.</given-names></name><name><surname>Tamura</surname><given-names>E. K.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Effects of chronic treatment with new strains of <italic>Lactobacillus plantarum</italic> on cognitive, anxiety-and depressive-like behaviors in male mice</article-title>. <source>PLoS One</source>
<volume>15</volume>:<fpage>e0234037</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0234037</pub-id>, PMID: <pub-id pub-id-type="pmid">32559185</pub-id>
</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bettler</surname><given-names>B.</given-names></name><name><surname>Kaupmann</surname><given-names>K.</given-names></name><name><surname>Mosbacher</surname><given-names>J.</given-names></name><name><surname>Gassmann</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Molecular structure and physiological functions of GABA(B) receptors</article-title>. <source>Physiol. Rev.</source>
<volume>84</volume>, <fpage>835</fpage>&#x02013;<lpage>867</lpage>. doi: <pub-id pub-id-type="doi">10.1152/physrev.00036.2003</pub-id>, PMID: <pub-id pub-id-type="pmid">15269338</pub-id>
</mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhat</surname><given-names>A.</given-names></name><name><surname>Shafi</surname><given-names>F.</given-names></name><name><surname>El Solh</surname><given-names>A. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Pharmacotherapy of insomnia</article-title>. <source>Expert. Opin. Pharmacother.</source>
<volume>9</volume>, <fpage>351</fpage>&#x02013;<lpage>362</lpage>. doi: <pub-id pub-id-type="doi">10.1517/14656566.9.3.351</pub-id><pub-id pub-id-type="pmid">18220487</pub-id>
</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blake</surname><given-names>M. J.</given-names></name><name><surname>Trinder</surname><given-names>J. A.</given-names></name><name><surname>Allen</surname><given-names>N. B.</given-names></name></person-group> (<year>2018</year>). <article-title>Mechanisms underlying the association between insomnia, anxiety, and depression in adolescence: implications for behavioral sleep interventions</article-title>. <source>Clin. Psychol. Rev.</source>
<volume>63</volume>, <fpage>25</fpage>&#x02013;<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cpr.2018.05.006</pub-id>, PMID: <pub-id pub-id-type="pmid">29879564</pub-id>
</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boonstra</surname><given-names>E.</given-names></name><name><surname>de Kleijn</surname><given-names>R.</given-names></name><name><surname>Colzato</surname><given-names>L. S.</given-names></name><name><surname>Alkemade</surname><given-names>A.</given-names></name><name><surname>Forstmann</surname><given-names>B. U.</given-names></name><name><surname>Nieuwenhuis</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Neurotransmitters as food supplements: the effects of GABA on brain and behavior</article-title>. <source>Front. Psychol.</source>
<volume>6</volume>:<fpage>1520</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyg.2015.01520</pub-id>, PMID: <pub-id pub-id-type="pmid">26500584</pub-id>
</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bormann</surname><given-names>J.</given-names></name></person-group> (<year>1988</year>). <article-title>Electrophysiology of GABAA and GABAB receptor subtypes</article-title>. <source>Trends Neurosci.</source>
<volume>11</volume>, <fpage>112</fpage>&#x02013;<lpage>116</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0166-2236(88)90156-7</pub-id>, PMID: <pub-id pub-id-type="pmid">2465608</pub-id>
</mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowery</surname><given-names>N. G.</given-names></name><name><surname>Doble</surname><given-names>A.</given-names></name><name><surname>Hill</surname><given-names>D. R.</given-names></name><name><surname>Hudson</surname><given-names>A. L.</given-names></name><name><surname>Shaw</surname><given-names>J. S.</given-names></name><name><surname>Turnbull</surname><given-names>M. J.</given-names></name></person-group> (<year>1979</year>). <article-title>Baclofen: a selective agonist for a novel type of GABA receptor proceedings</article-title>. <source>Br. J. Pharmacol.</source>
<volume>67</volume>, <fpage>444</fpage>&#x02013;<lpage>445</lpage>.</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bragantini</surname><given-names>D.</given-names></name><name><surname>Sivertsen</surname><given-names>B.</given-names></name><name><surname>Gehrman</surname><given-names>P.</given-names></name><name><surname>Lydersen</surname><given-names>S.</given-names></name><name><surname>G&#x000fc;zey</surname><given-names>I. C.</given-names></name></person-group> (<year>2019</year>). <article-title>Differences in anxiety levels among symptoms of insomnia. The HUNT study</article-title>. <source>Sleep Health</source>
<volume>5</volume>, <fpage>370</fpage>&#x02013;<lpage>375</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.sleh.2019.01.002</pub-id>, PMID: <pub-id pub-id-type="pmid">31400882</pub-id>
</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bravo</surname><given-names>J. A.</given-names></name><name><surname>Forsythe</surname><given-names>P.</given-names></name><name><surname>Chew</surname><given-names>M. V.</given-names></name><name><surname>Escaravage</surname><given-names>E.</given-names></name><name><surname>Savignac</surname><given-names>H. M.</given-names></name><name><surname>Dinan</surname><given-names>T. G.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>
<volume>108</volume>, <fpage>16050</fpage>&#x02013;<lpage>16055</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1102999108</pub-id>, PMID: <pub-id pub-id-type="pmid">21876150</pub-id>
</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breit</surname><given-names>S.</given-names></name><name><surname>Kupferberg</surname><given-names>A.</given-names></name><name><surname>Rogler</surname><given-names>G.</given-names></name><name><surname>Hasler</surname><given-names>G.</given-names></name></person-group> (<year>2018</year>). <article-title>Vagus nerve as modulator of the brain-gut Axis in psychiatric and inflammatory disorders</article-title>. <source>Front. Psych.</source>
<volume>9</volume>:<fpage>44</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyt.2018.00044</pub-id>, PMID: <pub-id pub-id-type="pmid">29593576</pub-id>
</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brightman</surname><given-names>M. W.</given-names></name><name><surname>Reese</surname><given-names>T. S.</given-names></name></person-group> (<year>1969</year>). <article-title>Junctions between intimately apposed cell membranes in the vertebrate brain</article-title>. <source>J. Cell Biol.</source>
<volume>40</volume>, <fpage>648</fpage>&#x02013;<lpage>677</lpage>. doi: <pub-id pub-id-type="doi">10.1083/jcb.40.3.648</pub-id>, PMID: <pub-id pub-id-type="pmid">5765759</pub-id>
</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckley</surname><given-names>T. M.</given-names></name><name><surname>Schatzberg</surname><given-names>A. F.</given-names></name></person-group> (<year>2005</year>). <article-title>On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders</article-title>. <source>J. Clin. Endocrinol. Metab.</source>
<volume>90</volume>, <fpage>3106</fpage>&#x02013;<lpage>3114</lpage>. doi: <pub-id pub-id-type="doi">10.1210/jc.2004-1056</pub-id>, PMID: <pub-id pub-id-type="pmid">15728214</pub-id>
</mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buysse</surname><given-names>D. J.</given-names></name><name><surname>Thompson</surname><given-names>W.</given-names></name><name><surname>Scott</surname><given-names>J.</given-names></name><name><surname>Franzen</surname><given-names>P. L.</given-names></name><name><surname>Germain</surname><given-names>A.</given-names></name><name><surname>Hall</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Daytime symptoms in primary insomnia: a prospective analysis using ecological momentary assessment</article-title>. <source>Sleep Med.</source>
<volume>8</volume>, <fpage>198</fpage>&#x02013;<lpage>208</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.sleep.2006.10.006</pub-id>, PMID: <pub-id pub-id-type="pmid">17368098</pub-id>
</mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byrd</surname><given-names>J. B.</given-names></name><name><surname>Brook</surname><given-names>R. D.</given-names></name></person-group> (<year>2014</year>). <article-title>Anxiety in the "age of hypertension"</article-title>. <source>Curr. Hypertens. Rep.</source>
<volume>16</volume>:<fpage>486</fpage>. doi: <pub-id pub-id-type="doi">10.1007/s11906-014-0486-0</pub-id>, PMID: <pub-id pub-id-type="pmid">25164965</pub-id>
</mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byun</surname><given-names>J. I.</given-names></name><name><surname>Shin</surname><given-names>Y. Y.</given-names></name><name><surname>Chung</surname><given-names>S. E.</given-names></name><name><surname>Shin</surname><given-names>W. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Safety and efficacy of gamma-aminobutyric acid from fermented Rice germ in patients with insomnia symptoms: a randomized, double-blind trial</article-title>. <source>J. Clin. Neurol.</source>
<volume>14</volume>, <fpage>291</fpage>&#x02013;<lpage>295</lpage>. doi: <pub-id pub-id-type="doi">10.3988/jcn.2018.14.3.291</pub-id>, PMID: <pub-id pub-id-type="pmid">29856155</pub-id>
</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>S.</given-names></name><name><surname>Gao</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>O.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Zhu</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Evaluation of &#x003b3;-aminobutyric acid, phytate and antioxidant activity of tempeh-like fermented oats (<italic>Avena sativa</italic> L.) prepared with different filamentous fungi</article-title>. <source>J. Food Sci. Technol.</source>
<volume>51</volume>, <fpage>2544</fpage>&#x02013;<lpage>2551</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s13197-012-0748-2</pub-id>, PMID: <pub-id pub-id-type="pmid">25328194</pub-id>
</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>L.</given-names></name><name><surname>Tao</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Cui</surname><given-names>C.</given-names></name></person-group> (<year>2022</year>). <article-title>The anti-anxiety/depression effect of a combined complex of casein hydrolysate and &#x003b3;-aminobutyric acid on C57BL/6 mice</article-title>. <source>Front. Nutr.</source>
<volume>9</volume>:<fpage>971853</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnut.2022.971853</pub-id>, PMID: <pub-id pub-id-type="pmid">36245498</pub-id>
</mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Calm</surname><given-names>C. C.</given-names></name></person-group> (<year>2024</year>). <article-title>Mental health 2024 statistics: the growing impact of anxiety</article-title>. Available online at: <ext-link xlink:href="https://www.laurageftman.com/blog/mental-health-2024-statistics-anxiety" ext-link-type="uri">https://www.laurageftman.com/blog/mental-health-2024-statistics-anxiety</ext-link>.</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlisi</surname><given-names>C. O.</given-names></name><name><surname>Hilbert</surname><given-names>K.</given-names></name><name><surname>Guyer</surname><given-names>A. E.</given-names></name><name><surname>Ernst</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Sleep-amount differentially affects fear-processing neural circuitry in pediatric anxiety: a preliminary fMRI investigation</article-title>. <source>Cogn. Affect. Behav. Neurosci.</source>
<volume>17</volume>, <fpage>1098</fpage>&#x02013;<lpage>1113</lpage>. doi: <pub-id pub-id-type="doi">10.3758/s13415-017-0535-7</pub-id>, PMID: <pub-id pub-id-type="pmid">28913727</pub-id>
</mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaaya</surname><given-names>N.</given-names></name><name><surname>Battle</surname><given-names>A. R.</given-names></name><name><surname>Johnson</surname><given-names>L. R.</given-names></name></person-group> (<year>2018</year>). <article-title>An update on contextual fear memory mechanisms: transition between amygdala and Hippocampus</article-title>. <source>Neurosci. Biobehav. Rev.</source>
<volume>92</volume>, <fpage>43</fpage>&#x02013;<lpage>54</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neubiorev.2018.05.013</pub-id>, PMID: <pub-id pub-id-type="pmid">29752958</pub-id>
</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chellappa</surname><given-names>S. L.</given-names></name><name><surname>Aeschbach</surname><given-names>D.</given-names></name></person-group> (<year>2022</year>). <article-title>Sleep and anxiety: from mechanisms to interventions</article-title>. <source>Sleep Med. Rev.</source>
<volume>61</volume>:<fpage>101583</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.smrv.2021.101583</pub-id>, PMID: <pub-id pub-id-type="pmid">34979437</pub-id>
</mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Fei</surname><given-names>Y. J.</given-names></name><name><surname>Anderson</surname><given-names>C. M.</given-names></name><name><surname>Wake</surname><given-names>K. A.</given-names></name><name><surname>Miyauchi</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>W.</given-names></name><etal/></person-group>. (<year>2003</year>). <article-title>Structure, function and immunolocalization of a proton-coupled amino acid transporter (hPAT1) in the human intestinal cell line Caco-2</article-title>. <source>J. Physiol.</source>
<volume>546</volume>, <fpage>349</fpage>&#x02013;<lpage>361</lpage>. doi: <pub-id pub-id-type="doi">10.1113/jphysiol.2002.026500</pub-id>, PMID: <pub-id pub-id-type="pmid">12527723</pub-id>
</mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Jia</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Hao</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>The combined use of gamma-aminobutyric acid and walnut peptide enhances sleep in mice</article-title>. <source>Ann. Palliat. Med.</source>
<volume>10</volume>, <fpage>11074</fpage>&#x02013;<lpage>11082</lpage>. doi: <pub-id pub-id-type="doi">10.21037/apm-21-2798</pub-id>, PMID: <pub-id pub-id-type="pmid">34763469</pub-id>
</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>T. C.</given-names></name><name><surname>Tsai</surname><given-names>J. F.</given-names></name></person-group> (<year>2009</year>). <article-title>GABA tea helps sleep</article-title>. <source>J. Altern. Complement. Med.</source>
<volume>15</volume>, <fpage>697</fpage>&#x02013;<lpage>698</lpage>. doi: <pub-id pub-id-type="doi">10.1089/acm.2009.0023</pub-id>, PMID: <pub-id pub-id-type="pmid">19534613</pub-id>
</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cullinan</surname><given-names>W. E.</given-names></name><name><surname>Ziegler</surname><given-names>D. R.</given-names></name><name><surname>Herman</surname><given-names>J. P.</given-names></name></person-group> (<year>2008</year>). <article-title>Functional role of local GABAergic influences on the HPA axis</article-title>. <source>Brain Struct. Funct.</source>
<volume>213</volume>, <fpage>63</fpage>&#x02013;<lpage>72</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00429-008-0192-2</pub-id>, PMID: <pub-id pub-id-type="pmid">18696110</pub-id>
</mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deschaux</surname><given-names>O.</given-names></name><name><surname>Froestl</surname><given-names>W.</given-names></name><name><surname>Gottesmann</surname><given-names>C.</given-names></name></person-group> (<year>2006</year>). <article-title>Influence of a GABA(B) and GABA(C) receptor antagonist on sleep-waking cycle in the rat</article-title>. <source>Eur. J. Pharmacol.</source>
<volume>535</volume>, <fpage>177</fpage>&#x02013;<lpage>181</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejphar.2006.01.066</pub-id>, PMID: <pub-id pub-id-type="pmid">16540106</pub-id>
</mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Pierro</surname><given-names>F.</given-names></name><name><surname>Sisti</surname><given-names>D.</given-names></name><name><surname>Rocchi</surname><given-names>M.</given-names></name><name><surname>Belli</surname><given-names>A.</given-names></name><name><surname>Bertuccioli</surname><given-names>A.</given-names></name><name><surname>Cazzaniga</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2024</year>). <article-title>Effects of <italic>Melissa officinalis</italic> Phytosome on sleep quality: results of a prospective, double-blind, placebo-controlled, and cross-over study</article-title>. <source>Nutrients</source>
<volume>16</volume>:<fpage>4199</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu16234199</pub-id>, PMID: <pub-id pub-id-type="pmid">39683592</pub-id>
</mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubourget</surname><given-names>R.</given-names></name><name><surname>Sangare</surname><given-names>A.</given-names></name><name><surname>Geoffroy</surname><given-names>H.</given-names></name><name><surname>Gallopin</surname><given-names>T.</given-names></name><name><surname>Rancillac</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Multiparametric characterization of neuronal subpopulations in the ventrolateral preoptic nucleus</article-title>. <source>Brain Struct. Funct.</source>
<volume>222</volume>, <fpage>1153</fpage>&#x02013;<lpage>1167</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00429-016-1265-2</pub-id>, PMID: <pub-id pub-id-type="pmid">27393010</pub-id>
</mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duranti</surname><given-names>S.</given-names></name><name><surname>Ruiz</surname><given-names>L.</given-names></name><name><surname>Lugli</surname><given-names>G. A.</given-names></name><name><surname>Tames</surname><given-names>H.</given-names></name><name><surname>Milani</surname><given-names>C.</given-names></name><name><surname>Mancabelli</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title><italic>Bifidobacterium adolescentis</italic> as a key member of the human gut microbiota in the production of GABA</article-title>. <source>Sci. Rep.</source>
<volume>10</volume>:<fpage>14112</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-020-70986-z</pub-id>, PMID: <pub-id pub-id-type="pmid">32839473</pub-id>
</mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faucher</surname><given-names>P.</given-names></name><name><surname>Dries</surname><given-names>A.</given-names></name><name><surname>Mousset</surname><given-names>P. Y.</given-names></name><name><surname>Leboyer</surname><given-names>M.</given-names></name><name><surname>Dore</surname><given-names>J.</given-names></name><name><surname>Beracochea</surname><given-names>D.</given-names></name></person-group> (<year>2022</year>). <article-title>Synergistic effects of Lacticaseibacillus rhamnosus GG, glutamine, and curcumin on chronic unpredictable mild stress-induced depression in a mouse model</article-title>. <source>Benef Microbes</source>
<volume>13</volume>, <fpage>253</fpage>&#x02013;<lpage>264</lpage>. doi: <pub-id pub-id-type="doi">10.3920/bm2021.0188</pub-id>, PMID: <pub-id pub-id-type="pmid">35786408</pub-id>
</mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feehily</surname><given-names>C.</given-names></name><name><surname>Karatzas</surname><given-names>K. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Role of glutamate metabolism in bacterial responses towards acid and other stresses</article-title>. <source>J. Appl. Microbiol.</source>
<volume>114</volume>, <fpage>11</fpage>&#x02013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2672.2012.05434.x</pub-id>, PMID: <pub-id pub-id-type="pmid">22924898</pub-id>
</mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felice</surname><given-names>D.</given-names></name><name><surname>Cryan</surname><given-names>J. F.</given-names></name><name><surname>O'Leary</surname><given-names>O. F.</given-names></name></person-group> (<year>2022</year>). <article-title>GABA(B) receptors: anxiety and mood disorders</article-title>. <source>Curr. Top. Behav. Neurosci.</source>
<volume>52</volume>, <fpage>241</fpage>&#x02013;<lpage>265</lpage>. doi: <pub-id pub-id-type="doi">10.1007/7854_2020_171</pub-id>, PMID: <pub-id pub-id-type="pmid">32860591</pub-id>
</mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>H. H.</given-names></name><name><surname>L&#x000f6;scher</surname><given-names>W.</given-names></name></person-group> (<year>1980</year>). <article-title>Cetyl GABA: effect on convulsant thresholds in mice and acute toxicity</article-title>. <source>Neuropharmacology</source>
<volume>19</volume>, <fpage>217</fpage>&#x02013;<lpage>220</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0028-3908(80)90141-0</pub-id>, PMID: <pub-id pub-id-type="pmid">7360336</pub-id>
</mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giustino</surname><given-names>T. F.</given-names></name><name><surname>Maren</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Noradrenergic modulation of fear conditioning and extinction</article-title>. <source>Front. Behav. Neurosci.</source>
<volume>12</volume>:<fpage>43</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnbeh.2018.00043</pub-id>, PMID: <pub-id pub-id-type="pmid">29593511</pub-id>
</mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>L.</given-names></name><name><surname>Shi</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>R.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>The abnormal functional connectivity in the locus Coeruleus-norepinephrine system associated with anxiety symptom in chronic insomnia disorder</article-title>. <source>Front. Neurosci.</source>
<volume>15</volume>:<fpage>678465</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnins.2021.678465</pub-id>, PMID: <pub-id pub-id-type="pmid">34093121</pub-id>
</mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenblatt</surname><given-names>D. J.</given-names></name><name><surname>Harmatz</surname><given-names>J. S.</given-names></name><name><surname>Shader</surname><given-names>R. I.</given-names></name></person-group> (<year>2020</year>). <article-title>Diazepam in the elderly: looking Back, ahead, and at the evidence</article-title>. <source>J. Clin. Psychopharmacol.</source>
<volume>40</volume>, <fpage>215</fpage>&#x02013;<lpage>219</lpage>. doi: <pub-id pub-id-type="doi">10.1097/jcp.0000000000001213</pub-id>, PMID: <pub-id pub-id-type="pmid">32332456</pub-id>
</mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajisoltani</surname><given-names>R.</given-names></name><name><surname>Meftahi</surname><given-names>G. H.</given-names></name></person-group> (<year>2024</year>). <article-title>Epinephrine injected into the basolateral amygdala affects anxiety-like behavior and memory performance in stressed rats</article-title>. <source>Neurosci. Lett.</source>
<volume>819</volume>:<fpage>137590</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neulet.2023.137590</pub-id>, PMID: <pub-id pub-id-type="pmid">38086522</pub-id>
</mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hepsomali</surname><given-names>P.</given-names></name><name><surname>Groeger</surname><given-names>J. A.</given-names></name><name><surname>Nishihira</surname><given-names>J.</given-names></name><name><surname>Scholey</surname><given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>Effects of Oral gamma-aminobutyric acid (GABA) administration on stress and sleep in humans: a systematic review</article-title>. <source>Front. Neurosci.</source>
<volume>14</volume>:<fpage>923</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnins.2020.00923</pub-id>, PMID: <pub-id pub-id-type="pmid">33041752</pub-id>
</mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinton</surname><given-names>T.</given-names></name><name><surname>Jelinek</surname><given-names>H. F.</given-names></name><name><surname>Viengkhou</surname><given-names>V.</given-names></name><name><surname>Johnston</surname><given-names>G. A.</given-names></name><name><surname>Matthews</surname><given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Effect of GABA-fortified oolong tea on reducing stress in a university student cohort</article-title>. <source>Front. Nutr.</source>
<volume>6</volume>:<fpage>27</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnut.2019.00027</pub-id>, PMID: <pub-id pub-id-type="pmid">30972340</pub-id>
</mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinton</surname><given-names>T.</given-names></name><name><surname>Johnston</surname><given-names>G. A. R.</given-names></name></person-group> (<year>2020</year>). <article-title>GABA-enriched teas as neuro-nutraceuticals</article-title>. <source>Neurochem. Int.</source>
<volume>141</volume>:<fpage>104895</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuint.2020.104895</pub-id>, PMID: <pub-id pub-id-type="pmid">33144101</pub-id>
</mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Thompson</surname><given-names>J. W.</given-names></name><name><surname>Yin</surname><given-names>T.</given-names></name><name><surname>Alexander</surname><given-names>P. B.</given-names></name><name><surname>Qin</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2022</year>). <article-title>Cancer-cell-derived GABA promotes &#x003b2;-catenin-mediated tumour growth and immunosuppression</article-title>. <source>Nat. Cell Biol.</source>
<volume>24</volume>, <fpage>230</fpage>&#x02013;<lpage>241</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41556-021-00820-9</pub-id>, PMID: <pub-id pub-id-type="pmid">35145222</pub-id>
</mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilgin</surname><given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>The adverse effects of psychotropic drugs as an endocrine disrupting chemicals on the hypothalamic-pituitary regulation in male</article-title>. <source>Life Sci.</source>
<volume>253</volume>:<fpage>117704</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.lfs.2020.117704</pub-id><pub-id pub-id-type="pmid">32339542</pub-id>
</mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>H. M.</given-names></name><name><surname>Jang</surname><given-names>S. E.</given-names></name><name><surname>Han</surname><given-names>M. J.</given-names></name><name><surname>Kim</surname><given-names>D. H.</given-names></name></person-group> (<year>2018</year>). <article-title>Anxiolytic-like effect of <italic>Bifidobacterium adolescentis</italic> IM38 in mice with or without immobilisation stress</article-title>. <source>Benef Microbes</source>
<volume>9</volume>, <fpage>123</fpage>&#x02013;<lpage>132</lpage>. doi: <pub-id pub-id-type="doi">10.3920/bm2016.0226</pub-id><pub-id pub-id-type="pmid">28969445</pub-id>
</mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janik</surname><given-names>R.</given-names></name><name><surname>Thomason</surname><given-names>L. A. M.</given-names></name><name><surname>Stanisz</surname><given-names>A. M.</given-names></name><name><surname>Forsythe</surname><given-names>P.</given-names></name><name><surname>Bienenstock</surname><given-names>J.</given-names></name><name><surname>Stanisz</surname><given-names>G. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Magnetic resonance spectroscopy reveals oral Lactobacillus promotion of increases in brain GABA, N-acetyl aspartate and glutamate</article-title>. <source>NeuroImage</source>
<volume>125</volume>, <fpage>988</fpage>&#x02013;<lpage>995</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2015.11.018</pub-id>, PMID: <pub-id pub-id-type="pmid">26577887</pub-id>
</mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>F.</given-names></name><name><surname>Kanbara</surname><given-names>N.</given-names></name><name><surname>Obata</surname><given-names>K.</given-names></name></person-group> (<year>1999</year>). <article-title>GABA and histogenesis in fetal and neonatal mouse brain lacking both the isoforms of glutamic acid decarboxylase</article-title>. <source>Neurosci. Res.</source>
<volume>33</volume>, <fpage>187</fpage>&#x02013;<lpage>194</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0168-0102(99)00011-5</pub-id>, PMID: <pub-id pub-id-type="pmid">10211762</pub-id>
</mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>T.</given-names></name><name><surname>Gao</surname><given-names>F.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Hou</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title>Selenium-enriched <italic>Bifidobacterium longum</italic> DD98 relieves irritable bowel syndrome induced by chronic unpredictable mild stress in mice</article-title>. <source>Food Funct.</source>
<volume>14</volume>, <fpage>5355</fpage>&#x02013;<lpage>5374</lpage>. doi: <pub-id pub-id-type="doi">10.1039/d2fo03408e</pub-id>, PMID: <pub-id pub-id-type="pmid">37212199</pub-id>
</mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Z.</given-names></name><name><surname>Korol</surname><given-names>S. V.</given-names></name></person-group> (<year>2023</year>). <article-title>GABA signalling in human pancreatic islets</article-title>. <source>Front. Endocrinol. (Lausanne)</source>
<volume>14</volume>:<fpage>1059110</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fendo.2023.1059110</pub-id>, PMID: <pub-id pub-id-type="pmid">36891061</pub-id>
</mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>John</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>M. F.</given-names></name><name><surname>Boehmer</surname><given-names>L. N.</given-names></name><name><surname>Siegel</surname><given-names>J. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior</article-title>. <source>Neuron</source>
<volume>42</volume>, <fpage>619</fpage>&#x02013;<lpage>634</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0896-6273(04)00247-8</pub-id>, PMID: <pub-id pub-id-type="pmid">15157423</pub-id>
</mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>G. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Advantages of an antagonist: bicuculline and other GABA antagonists</article-title>. <source>Br. J. Pharmacol.</source>
<volume>169</volume>, <fpage>328</fpage>&#x02013;<lpage>336</lpage>. doi: <pub-id pub-id-type="doi">10.1111/bph.12127</pub-id>, PMID: <pub-id pub-id-type="pmid">23425285</pub-id>
</mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juruena</surname><given-names>M. F.</given-names></name><name><surname>Eror</surname><given-names>F.</given-names></name><name><surname>Cleare</surname><given-names>A. J.</given-names></name><name><surname>Young</surname><given-names>A. H.</given-names></name></person-group> (<year>2020</year>). <article-title>The role of early life stress in HPA Axis and anxiety</article-title>. <source>Adv. Exp. Med. Biol.</source>
<volume>1191</volume>, <fpage>141</fpage>&#x02013;<lpage>153</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-981-32-9705-0_9</pub-id>, PMID: <pub-id pub-id-type="pmid">32002927</pub-id>
</mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalmbach</surname><given-names>D. A.</given-names></name><name><surname>Anderson</surname><given-names>J. R.</given-names></name><name><surname>Drake</surname><given-names>C. L.</given-names></name></person-group> (<year>2018</year>). <article-title>The impact of stress on sleep: pathogenic sleep reactivity as a vulnerability to insomnia and circadian disorders</article-title>. <source>J. Sleep Res.</source>
<volume>27</volume>:<fpage>e12710</fpage>. doi: <pub-id pub-id-type="doi">10.1111/jsr.12710</pub-id>, PMID: <pub-id pub-id-type="pmid">29797753</pub-id>
</mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kandola</surname><given-names>A.</given-names></name><name><surname>Stubbs</surname><given-names>B.</given-names></name></person-group> (<year>2020</year>). <article-title>Exercise and anxiety</article-title>. <source>Adv. Exp. Med. Biol.</source>
<volume>1228</volume>, <fpage>345</fpage>&#x02013;<lpage>352</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-981-15-1792-1_23</pub-id>, PMID: <pub-id pub-id-type="pmid">32342469</pub-id>
</mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehira</surname><given-names>T.</given-names></name><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Nakamura</surname><given-names>K.</given-names></name><name><surname>Horie</surname><given-names>K.</given-names></name><name><surname>Horie</surname><given-names>N.</given-names></name><name><surname>Furugori</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Relieving occupational fatigue by consumption of a beverage containing &#x003b3;-amino butyric acid</article-title>. <source>J. Nutr. Sci. Vitaminol. (Tokyo)</source>
<volume>57</volume>, <fpage>9</fpage>&#x02013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.3177/jnsv.57.9</pub-id>, PMID: <pub-id pub-id-type="pmid">21512285</pub-id>
</mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>S.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Mayer</surname><given-names>M. J.</given-names></name><name><surname>Neuert</surname><given-names>S.</given-names></name><name><surname>Narbad</surname><given-names>A.</given-names></name><name><surname>Kaur</surname><given-names>S.</given-names></name></person-group> (<year>2023</year>). <article-title>Beneficial effects of GABA-producing potential probiotic Limosilactobacillus fermentum L18 of human origin on intestinal permeability and human gut microbiota</article-title>. <source>Microb. Cell Factories</source>
<volume>22</volume>:<fpage>256</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12934-023-02264-2</pub-id>, PMID: <pub-id pub-id-type="pmid">38087304</pub-id>
</mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. J.</given-names></name><name><surname>Hibbs</surname><given-names>R. E.</given-names></name></person-group> (<year>2021</year>). <article-title>Direct structural insights into GABA(a) receptor pharmacology</article-title>. <source>Trends Biochem. Sci.</source>
<volume>46</volume>, <fpage>502</fpage>&#x02013;<lpage>517</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tibs.2021.01.011</pub-id>, PMID: <pub-id pub-id-type="pmid">33674151</pub-id>
</mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Jo</surname><given-names>K.</given-names></name><name><surname>Hong</surname><given-names>K. B.</given-names></name><name><surname>Han</surname><given-names>S. H.</given-names></name><name><surname>Suh</surname><given-names>H. J.</given-names></name></person-group> (<year>2019</year>). <article-title>GABA and l-theanine mixture decreases sleep latency and improves NREM sleep</article-title>. <source>Pharm. Biol.</source>
<volume>57</volume>, <fpage>65</fpage>&#x02013;<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.1080/13880209.2018.1557698</pub-id>, PMID: <pub-id pub-id-type="pmid">30707852</pub-id>
</mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H. S.</given-names></name><name><surname>Lee</surname><given-names>E. J.</given-names></name><name><surname>Lim</surname><given-names>S. T.</given-names></name><name><surname>Han</surname><given-names>J. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Self-enhancement of GABA in rice bran using various stress treatments</article-title>. <source>Food Chem.</source>
<volume>172</volume>, <fpage>657</fpage>&#x02013;<lpage>662</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.foodchem.2014.09.107</pub-id>, PMID: <pub-id pub-id-type="pmid">25442603</pub-id>
</mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knudsen</surname><given-names>G. M.</given-names></name><name><surname>Poulsen</surname><given-names>H. E.</given-names></name><name><surname>Paulson</surname><given-names>O. B.</given-names></name></person-group> (<year>1988</year>). <article-title>Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy. No evidence for increased GABA-transport</article-title>. <source>J. Hepatol.</source>
<volume>6</volume>, <fpage>187</fpage>&#x02013;<lpage>192</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0168-8278(88)80030-8</pub-id>, PMID: <pub-id pub-id-type="pmid">3411098</pub-id>
</mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>E. M.</given-names></name><name><surname>Estabrooke</surname><given-names>I. V.</given-names></name><name><surname>McCarthy</surname><given-names>M.</given-names></name><name><surname>Scammell</surname><given-names>T. E.</given-names></name></person-group> (<year>2003</year>). <article-title>Wake-related activity of tuberomammillary neurons in rats</article-title>. <source>Brain Res.</source>
<volume>992</volume>, <fpage>220</fpage>&#x02013;<lpage>226</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.brainres.2003.08.044</pub-id>, PMID: <pub-id pub-id-type="pmid">14625060</pub-id>
</mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krettek</surname><given-names>J. E.</given-names></name><name><surname>Price</surname><given-names>J. L.</given-names></name></person-group> (<year>1978</year>). <article-title>A description of the amygdaloid complex in the rat and cat with observations on intra-amygdaloid axonal connections</article-title>. <source>J. Comp. Neurol.</source>
<volume>178</volume>, <fpage>255</fpage>&#x02013;<lpage>279</lpage>. doi: <pub-id pub-id-type="doi">10.1002/cne.901780205</pub-id><pub-id pub-id-type="pmid">627626</pub-id>
</mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kristensen</surname><given-names>A. S.</given-names></name><name><surname>Andersen</surname><given-names>J.</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>T. N.</given-names></name><name><surname>S&#x000f8;rensen</surname><given-names>L.</given-names></name><name><surname>Eriksen</surname><given-names>J.</given-names></name><name><surname>Loland</surname><given-names>C. J.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>SLC6 neurotransmitter transporters: structure, function, and regulation</article-title>. <source>Pharmacol. Rev.</source>
<volume>63</volume>, <fpage>585</fpage>&#x02013;<lpage>640</lpage>. doi: <pub-id pub-id-type="doi">10.1124/pr.108.000869</pub-id>, PMID: <pub-id pub-id-type="pmid">21752877</pub-id>
</mixed-citation></ref><ref id="ref67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lan</surname><given-names>Y. J.</given-names></name><name><surname>Tan</surname><given-names>S. I.</given-names></name><name><surname>Cheng</surname><given-names>S. Y.</given-names></name><name><surname>Ting</surname><given-names>W. W.</given-names></name><name><surname>Xue</surname><given-names>C.</given-names></name><name><surname>Lin</surname><given-names>T. H.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Development of <italic>Escherichia coli</italic> Nissle 1917 derivative by CRISPR/Cas9 and application for gamma-aminobutyric acid (GABA) production in antibiotic-free system</article-title>. <source>Biochem. Eng. J.</source>
<volume>168</volume>:<fpage>107952</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bej.2021.107952</pub-id></mixed-citation></ref><ref id="ref68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebovich</surname><given-names>M.</given-names></name><name><surname>Andrews</surname><given-names>L. B.</given-names></name></person-group> (<year>2022</year>). <article-title>Surveying the genetic design space for transcription factor-based metabolite biosensors: synthetic gamma-aminobutyric acid and propionate biosensors in <italic>E. coli</italic> Nissle 1917</article-title>. <source>Front. Bioeng. Biotechnol.</source>
<volume>10</volume>:<fpage>938056</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fbioe.2022.938056</pub-id>, PMID: <pub-id pub-id-type="pmid">36091463</pub-id>
</mixed-citation></ref><ref id="ref69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebovich</surname><given-names>M.</given-names></name><name><surname>Andrews</surname><given-names>L. B.</given-names></name></person-group> (<year>2023</year>). <article-title>Genetic circuits for feedback control of gamma-aminobutyric acid biosynthesis in probiotic <italic>Escherichia coli</italic> Nissle 1917</article-title>. <source>bioRxiv</source>. doi: <pub-id pub-id-type="doi">10.1101/2023.06.09.544351</pub-id>, PMID: <pub-id pub-id-type="pmid">37333167</pub-id>
</mixed-citation></ref><ref id="ref70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeDoux</surname><given-names>J. E.</given-names></name></person-group> (<year>2000</year>). <article-title>Emotion circuits in the brain</article-title>. <source>Annu. Rev. Neurosci.</source>
<volume>23</volume>, <fpage>155</fpage>&#x02013;<lpage>184</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev.neuro.23.1.155</pub-id>, PMID: <pub-id pub-id-type="pmid">10845062</pub-id>
</mixed-citation></ref><ref id="ref71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>J.</given-names></name><name><surname>Shen</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Ma</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wei</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title>Comparative chemical characterization of potato powders using (1)H NMR spectroscopy and Chemometrics</article-title>. <source>Plant Foods Hum. Nutr.</source>
<volume>78</volume>, <fpage>590</fpage>&#x02013;<lpage>596</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11130-023-01088-0</pub-id>, PMID: <pub-id pub-id-type="pmid">37566209</pub-id>
</mixed-citation></ref><ref id="ref72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Mao</surname><given-names>F.</given-names></name><name><surname>Mao</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Study of GABA in healthy volunteers: pharmacokinetics and pharmacodynamics</article-title>. <source>Front. Pharmacol.</source>
<volume>6</volume>:<fpage>260</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2015.00260</pub-id>, PMID: <pub-id pub-id-type="pmid">26617516</pub-id>
</mixed-citation></ref><ref id="ref73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>G.</given-names></name><name><surname>Khan</surname><given-names>I.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2022</year>). <article-title>Overcoming anxiety disorder by probiotic Lactiplantibacillus plantarum LZU-J-TSL6 through regulating intestinal homeostasis</article-title>. <source>Food Secur.</source>
<volume>11</volume>:<fpage>3596</fpage>. doi: <pub-id pub-id-type="doi">10.3390/foods11223596</pub-id>, PMID: <pub-id pub-id-type="pmid">36429192</pub-id>
</mixed-citation></ref><ref id="ref74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M. Q.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>Q. L.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>B. R.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2022</year>). <article-title>Structure-guided discovery of food-derived GABA-T inhibitors as hunters for anti-anxiety compounds</article-title>. <source>Food Funct.</source>
<volume>13</volume>, <fpage>12674</fpage>&#x02013;<lpage>12685</lpage>. doi: <pub-id pub-id-type="doi">10.1039/d2fo01315k</pub-id>, PMID: <pub-id pub-id-type="pmid">36382616</pub-id>
</mixed-citation></ref><ref id="ref75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Yi</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name></person-group> (<year>2022</year>). <article-title>Carrot-based fermentation juice rich in sleep-promoting components improved sleep in mice</article-title>. <source>Front. Nutr.</source>
<volume>9</volume>:<fpage>1043055</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnut.2022.1043055</pub-id>, PMID: <pub-id pub-id-type="pmid">36523330</pub-id>
</mixed-citation></ref><ref id="ref76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liwinski</surname><given-names>T.</given-names></name><name><surname>Lang</surname><given-names>U. E.</given-names></name><name><surname>Br&#x000fc;hl</surname><given-names>A. B.</given-names></name><name><surname>Schneider</surname><given-names>E.</given-names></name></person-group> (<year>2023</year>). <article-title>Exploring the therapeutic potential of gamma-aminobutyric acid in stress and depressive disorders through the gut-brain Axis</article-title>. <source>Biomedicines</source>
<volume>11</volume>:<fpage>3128</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biomedicines11123128</pub-id>, PMID: <pub-id pub-id-type="pmid">38137351</pub-id>
</mixed-citation></ref><ref id="ref77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luck</surname><given-names>B.</given-names></name><name><surname>Horvath</surname><given-names>T. D.</given-names></name><name><surname>Engevik</surname><given-names>K. A.</given-names></name><name><surname>Ruan</surname><given-names>W.</given-names></name><name><surname>Haidacher</surname><given-names>S. J.</given-names></name><name><surname>Hoch</surname><given-names>K. M.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Neurotransmitter profiles are altered in the gut and brain of mice mono-associated with <italic>Bifidobacterium dentium</italic></article-title>. <source>Biomol. Ther.</source>
<volume>11</volume>:<fpage>1091</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biom11081091</pub-id>, PMID: <pub-id pub-id-type="pmid">34439760</pub-id>
</mixed-citation></ref><ref id="ref78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Balle</surname><given-names>T.</given-names></name></person-group> (<year>2022</year>). <article-title>GABA(a) receptors as targets for anaesthetics and analgesics and promising candidates to help treat coronavirus infections: a mini-review</article-title>. <source>Basic Clin. Pharmacol. Toxicol.</source>
<volume>131</volume>, <fpage>443</fpage>&#x02013;<lpage>451</lpage>. doi: <pub-id pub-id-type="doi">10.1111/bcpt.13798</pub-id>, PMID: <pub-id pub-id-type="pmid">36165608</pub-id>
</mixed-citation></ref><ref id="ref79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lydiard</surname><given-names>R. B.</given-names></name></person-group> (<year>2003</year>). <article-title>The role of GABA in anxiety disorders</article-title>. <source>J. Clin. Psychiatry</source>
<volume>64</volume>, <fpage>21</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">12662130</pub-id>
</mixed-citation></ref><ref id="ref80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>J. P.</given-names></name><name><surname>Goers</surname><given-names>L.</given-names></name><name><surname>Lesser</surname><given-names>C. F.</given-names></name></person-group> (<year>2022</year>). <article-title>Emerging strategies for engineering <italic>Escherichia coli</italic> Nissle 1917-based therapeutics</article-title>. <source>Trends Pharmacol. Sci.</source>
<volume>43</volume>, <fpage>772</fpage>&#x02013;<lpage>786</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tips.2022.02.002</pub-id>, PMID: <pub-id pub-id-type="pmid">35232591</pub-id>
</mixed-citation></ref><ref id="ref81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattison</surname><given-names>K. A.</given-names></name><name><surname>Butler</surname><given-names>K. M.</given-names></name><name><surname>Inglis</surname><given-names>G. A. S.</given-names></name><name><surname>Dayan</surname><given-names>O.</given-names></name><name><surname>Boussidan</surname><given-names>H.</given-names></name><name><surname>Bhambhani</surname><given-names>V.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>SLC6A1 variants identified in epilepsy patients reduce &#x003b3;-aminobutyric acid transport</article-title>. <source>Epilepsia</source>
<volume>59</volume>, <fpage>e135</fpage>&#x02013;<lpage>e141</lpage>. doi: <pub-id pub-id-type="doi">10.1111/epi.14531</pub-id>, PMID: <pub-id pub-id-type="pmid">30132828</pub-id>
</mixed-citation></ref><ref id="ref82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzoli</surname><given-names>R.</given-names></name><name><surname>Pessione</surname><given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>The neuro-endocrinological role of microbial glutamate and GABA signaling</article-title>. <source>Front. Microbiol.</source>
<volume>7</volume>:<fpage>1934</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2016.01934</pub-id>, PMID: <pub-id pub-id-type="pmid">27965654</pub-id>
</mixed-citation></ref><ref id="ref83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merenstein</surname><given-names>D.</given-names></name><name><surname>Pot</surname><given-names>B.</given-names></name><name><surname>Leyer</surname><given-names>G.</given-names></name><name><surname>Ouwehand</surname><given-names>A. C.</given-names></name><name><surname>Preidis</surname><given-names>G. A.</given-names></name><name><surname>Elkins</surname><given-names>C. A.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title>Emerging issues in probiotic safety: 2023 perspectives</article-title>. <source>Gut Microbes</source>
<volume>15</volume>:<fpage>2185034</fpage>. doi: <pub-id pub-id-type="doi">10.1080/19490976.2023.2185034</pub-id>, PMID: <pub-id pub-id-type="pmid">36919522</pub-id>
</mixed-citation></ref><ref id="ref84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morin</surname><given-names>C. M.</given-names></name><name><surname>Benca</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Chronic insomnia</article-title>. <source>Lancet</source>
<volume>379</volume>, <fpage>1129</fpage>&#x02013;<lpage>1141</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0140-6736(11)60750-2</pub-id>, PMID: <pub-id pub-id-type="pmid">22265700</pub-id>
</mixed-citation></ref><ref id="ref85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morin</surname><given-names>C. M.</given-names></name><name><surname>Drake</surname><given-names>C. L.</given-names></name><name><surname>Harvey</surname><given-names>A. G.</given-names></name><name><surname>Krystal</surname><given-names>A. D.</given-names></name><name><surname>Manber</surname><given-names>R.</given-names></name><name><surname>Riemann</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Insomnia disorder</article-title>. <source>Nat. Rev. Dis. Primers</source>
<volume>1</volume>:<fpage>15026</fpage>. doi: <pub-id pub-id-type="doi">10.1038/nrdp.2015.26</pub-id><pub-id pub-id-type="pmid">27189779</pub-id>
</mixed-citation></ref><ref id="ref86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morin</surname><given-names>C. M.</given-names></name><name><surname>Jarrin</surname><given-names>D. C.</given-names></name></person-group> (<year>2022</year>). <article-title>Epidemiology of insomnia: prevalence, course, risk factors, and public health burden</article-title>. <source>Sleep Med. Clin.</source>
<volume>17</volume>, <fpage>173</fpage>&#x02013;<lpage>191</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jsmc.2022.03.003</pub-id>, PMID: <pub-id pub-id-type="pmid">35659072</pub-id>
</mixed-citation></ref><ref id="ref87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>L. S.</given-names></name><name><surname>McCall</surname><given-names>J. G.</given-names></name><name><surname>Charney</surname><given-names>D. S.</given-names></name><name><surname>Murrough</surname><given-names>J. W.</given-names></name></person-group> (<year>2020</year>). <article-title>The role of the locus coeruleus in the generation of pathological anxiety</article-title>. <source>Brain Neurosci. Adv.</source>
<volume>4</volume>:<fpage>2398212820930321</fpage>. doi: <pub-id pub-id-type="doi">10.1177/2398212820930321</pub-id>, PMID: <pub-id pub-id-type="pmid">32954002</pub-id>
</mixed-citation></ref><ref id="ref88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutoh</surname><given-names>N.</given-names></name><name><surname>Moriya</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Kato</surname><given-names>K.</given-names></name><name><surname>Arai</surname><given-names>S.</given-names></name><name><surname>Iwabuchi</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2024</year>). <article-title><italic>Bifidobacterium breve</italic> M-16V regulates the autonomic nervous system via the intestinal environment: a double-blind, placebo-controlled study</article-title>. <source>Behav. Brain Res.</source>
<volume>460</volume>:<fpage>114820</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbr.2023.114820</pub-id>, PMID: <pub-id pub-id-type="pmid">38128887</pub-id>
</mixed-citation></ref><ref id="ref89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>N&#x000e1;cher</surname><given-names>A.</given-names></name><name><surname>Polache</surname><given-names>A.</given-names></name><name><surname>Moll-Navarro</surname><given-names>M. J.</given-names></name><name><surname>Pl&#x000e1;-Delfina</surname><given-names>J. M.</given-names></name><name><surname>Merino</surname><given-names>M.</given-names></name></person-group> (<year>1994</year>). <article-title>Intestinal absorption pathway of gamma-aminobutyric acid in rat small intestine</article-title>. <source>Biopharm. Drug Dispos.</source>
<volume>15</volume>, <fpage>359</fpage>&#x02013;<lpage>371</lpage>. doi: <pub-id pub-id-type="doi">10.1002/bdd.2510150503</pub-id>, PMID: <pub-id pub-id-type="pmid">7981425</pub-id>
</mixed-citation></ref><ref id="ref90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>H.</given-names></name><name><surname>Takishima</surname><given-names>T.</given-names></name><name><surname>Kometani</surname><given-names>T.</given-names></name><name><surname>Yokogoshi</surname><given-names>H.</given-names></name></person-group> (<year>2009</year>). <article-title>Psychological stress-reducing effect of chocolate enriched with gamma-aminobutyric acid (GABA) in humans: assessment of stress using heart rate variability and salivary chromogranin a</article-title>. <source>Int. J. Food Sci. Nutr.</source>
<volume>60</volume>, <fpage>106</fpage>&#x02013;<lpage>113</lpage>. doi: <pub-id pub-id-type="doi">10.1080/09637480802558508</pub-id>, PMID: <pub-id pub-id-type="pmid">19462324</pub-id>
</mixed-citation></ref><ref id="ref91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngo</surname><given-names>D. H.</given-names></name><name><surname>Vo</surname><given-names>T. S.</given-names></name></person-group> (<year>2019</year>). <article-title>An updated review on pharmaceutical properties of gamma-aminobutyric acid</article-title>. <source>Molecules</source>
<volume>24</volume>:<fpage>2678</fpage>. doi: <pub-id pub-id-type="doi">10.3390/molecules24152678</pub-id>, PMID: <pub-id pub-id-type="pmid">31344785</pub-id>
</mixed-citation></ref><ref id="ref92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nutt</surname><given-names>D. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Overview of diagnosis and drug treatments of anxiety disorders</article-title>. <source>CNS Spectr.</source>
<volume>10</volume>, <fpage>49</fpage>&#x02013;<lpage>56</lpage>. doi: <pub-id pub-id-type="doi">10.1017/s1092852900009901</pub-id>, PMID: <pub-id pub-id-type="pmid">15618947</pub-id>
</mixed-citation></ref><ref id="ref93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oketch-Rabah</surname><given-names>H. A.</given-names></name><name><surname>Madden</surname><given-names>E. F.</given-names></name><name><surname>Roe</surname><given-names>A. L.</given-names></name><name><surname>Betz</surname><given-names>J. M.</given-names></name></person-group> (<year>2021</year>). <article-title>United States Pharmacopeia (USP) safety review of gamma-aminobutyric acid (GABA)</article-title>. <source>Nutrients</source>
<volume>13</volume>:<fpage>2742</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu13082742</pub-id>, PMID: <pub-id pub-id-type="pmid">34444905</pub-id>
</mixed-citation></ref><ref id="ref94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okita</surname><given-names>Y.</given-names></name><name><surname>Nakamura</surname><given-names>H.</given-names></name><name><surname>Kouda</surname><given-names>K.</given-names></name><name><surname>Takahashi</surname><given-names>I.</given-names></name><name><surname>Takaoka</surname><given-names>T.</given-names></name><name><surname>Kimura</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Effects of vegetable containing gamma-aminobutyric acid on the cardiac autonomic nervous system in healthy young people</article-title>. <source>J. Physiol. Anthropol.</source>
<volume>28</volume>, <fpage>101</fpage>&#x02013;<lpage>107</lpage>. doi: <pub-id pub-id-type="doi">10.2114/jpa2.28.101</pub-id>, PMID: <pub-id pub-id-type="pmid">19483370</pub-id>
</mixed-citation></ref><ref id="ref95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>R. W.</given-names></name><name><surname>Sieghart</surname><given-names>W.</given-names></name></person-group> (<year>2008</year>). <article-title>International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(a) receptors: classification on the basis of subunit composition, pharmacology, and function. Update</article-title>. <source>Pharmacol. Rev.</source>
<volume>60</volume>, <fpage>243</fpage>&#x02013;<lpage>260</lpage>. doi: <pub-id pub-id-type="doi">10.1124/pr.108.00505</pub-id>, PMID: <pub-id pub-id-type="pmid">18790874</pub-id>
</mixed-citation></ref><ref id="ref96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>C. A.</given-names></name><name><surname>Alfano</surname><given-names>C. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Sleep and emotion regulation: an organizing, integrative review</article-title>. <source>Sleep Med. Rev.</source>
<volume>31</volume>, <fpage>6</fpage>&#x02013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.smrv.2015.12.006</pub-id>, PMID: <pub-id pub-id-type="pmid">26899742</pub-id>
</mixed-citation></ref><ref id="ref97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>C. A.</given-names></name><name><surname>Alfano</surname><given-names>C. A.</given-names></name></person-group> (<year>2020</year>). <article-title>Anxiety modifies the emotional effects of sleep loss</article-title>. <source>Curr. Opin. Psychol.</source>
<volume>34</volume>, <fpage>100</fpage>&#x02013;<lpage>104</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.copsyc.2019.12.001</pub-id>, PMID: <pub-id pub-id-type="pmid">31915115</pub-id>
</mixed-citation></ref><ref id="ref98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>T.</given-names></name><name><surname>Cui</surname><given-names>M.</given-names></name><name><surname>Ma</surname><given-names>N.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2022</year>). <article-title>Light-sensitive <italic>Lactococcus lactis</italic> for microbe-gut-brain Axis regulating via Upconversion Optogenetic Micro-Nano system</article-title>. <source>ACS Nano</source>
<volume>16</volume>, <fpage>6049</fpage>&#x02013;<lpage>6063</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acsnano.1c11536</pub-id>, PMID: <pub-id pub-id-type="pmid">35362965</pub-id>
</mixed-citation></ref><ref id="ref99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardridge</surname><given-names>W. M.</given-names></name></person-group> (<year>2005</year>). <article-title>The blood-brain barrier: bottleneck in brain drug development</article-title>. <source>NeuroRx</source>
<volume>2</volume>, <fpage>3</fpage>&#x02013;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.1602/neurorx.2.1.3</pub-id>, PMID: <pub-id pub-id-type="pmid">15717053</pub-id>
</mixed-citation></ref><ref id="ref100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardridge</surname><given-names>W. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Blood-brain barrier delivery</article-title>. <source>Drug Discov. Today</source>
<volume>12</volume>, <fpage>54</fpage>&#x02013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.drudis.2006.10.013</pub-id>, PMID: <pub-id pub-id-type="pmid">17198973</pub-id>
</mixed-citation></ref><ref id="ref101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pillai</surname><given-names>V.</given-names></name><name><surname>Roth</surname><given-names>T.</given-names></name><name><surname>Mullins</surname><given-names>H. M.</given-names></name><name><surname>Drake</surname><given-names>C. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Moderators and mediators of the relationship between stress and insomnia: stressor chronicity, cognitive intrusion, and coping</article-title>. <source>Sleep</source>
<volume>37</volume>, <fpage>1199</fpage>&#x02013;<lpage>1208A</lpage>. doi: <pub-id pub-id-type="doi">10.5665/sleep.3838</pub-id>, PMID: <pub-id pub-id-type="pmid">25061248</pub-id>
</mixed-citation></ref><ref id="ref102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pokusaeva</surname><given-names>K.</given-names></name><name><surname>Johnson</surname><given-names>C.</given-names></name><name><surname>Luk</surname><given-names>B.</given-names></name><name><surname>Uribe</surname><given-names>G.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Oezguen</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>GABA-producing <italic>Bifidobacterium dentium</italic> modulates visceral sensitivity in the intestine</article-title>. <source>Neurogastroenterol. Motil.</source>
<volume>29</volume>:<fpage>e12904</fpage>. doi: <pub-id pub-id-type="doi">10.1111/nmo.12904</pub-id>, PMID: <pub-id pub-id-type="pmid">27458085</pub-id>
</mixed-citation></ref><ref id="ref103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Jia</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2024</year>). <article-title>Gut microbiota modulates neurotransmitter and gut-brain signaling</article-title>. <source>Microbiol. Res.</source>
<volume>287</volume>:<fpage>127858</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.micres.2024.127858</pub-id>, PMID: <pub-id pub-id-type="pmid">39106786</pub-id>
</mixed-citation></ref><ref id="ref104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Ren</surname><given-names>Y.</given-names></name><name><surname>Pruessner</surname><given-names>J. C.</given-names></name><etal/></person-group>. (<year>2022</year>). <article-title>The hippocampal-ventral medial prefrontal cortex Neurocircuitry involvement in the Association of Daily Life Stress with Acute Perceived Stress and Cortisol Responses</article-title>. <source>Psychosom. Med.</source>
<volume>84</volume>, <fpage>276</fpage>&#x02013;<lpage>287</lpage>. doi: <pub-id pub-id-type="doi">10.1097/psy.0000000000001058</pub-id>, PMID: <pub-id pub-id-type="pmid">35149637</pub-id>
</mixed-citation></ref><ref id="ref105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riedel</surname><given-names>A.</given-names></name><name><surname>Benz</surname><given-names>F.</given-names></name><name><surname>Deibert</surname><given-names>P.</given-names></name><name><surname>Barsch</surname><given-names>F.</given-names></name><name><surname>Frase</surname><given-names>L.</given-names></name><name><surname>Johann</surname><given-names>A. F.</given-names></name><etal/></person-group>. (<year>2024</year>). <article-title>The effect of physical exercise interventions on insomnia: a systematic review and meta-analysis</article-title>. <source>Sleep Med. Rev.</source>
<volume>76</volume>:<fpage>101948</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.smrv.2024.101948</pub-id>, PMID: <pub-id pub-id-type="pmid">38749363</pub-id>
</mixed-citation></ref><ref id="ref106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riemann</surname><given-names>D.</given-names></name><name><surname>Spiegelhalder</surname><given-names>K.</given-names></name><name><surname>Feige</surname><given-names>B.</given-names></name><name><surname>Voderholzer</surname><given-names>U.</given-names></name><name><surname>Berger</surname><given-names>M.</given-names></name><name><surname>Perlis</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>The hyperarousal model of insomnia: a review of the concept and its evidence</article-title>. <source>Sleep Med. Rev.</source>
<volume>14</volume>, <fpage>19</fpage>&#x02013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.smrv.2009.04.002</pub-id>, PMID: <pub-id pub-id-type="pmid">19481481</pub-id>
</mixed-citation></ref><ref id="ref107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>A. G.</given-names></name><name><surname>Peckins</surname><given-names>M. K.</given-names></name><name><surname>Gard</surname><given-names>A. M.</given-names></name><name><surname>Hein</surname><given-names>T. C.</given-names></name><name><surname>Hardi</surname><given-names>F. A.</given-names></name><name><surname>Mitchell</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2022</year>). <article-title>Amygdala reactivity during socioemotional processing and cortisol reactivity to a psychosocial stressor</article-title>. <source>Psychoneuroendocrinology</source>
<volume>144</volume>:<fpage>105855</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.psyneuen.2022.105855</pub-id>, PMID: <pub-id pub-id-type="pmid">35835021</pub-id>
</mixed-citation></ref><ref id="ref108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>O. J.</given-names></name><name><surname>Pike</surname><given-names>A. C.</given-names></name><name><surname>Cornwell</surname><given-names>B.</given-names></name><name><surname>Grillon</surname><given-names>C.</given-names></name></person-group> (<year>2019</year>). <article-title>The translational neural circuitry of anxiety</article-title>. <source>J. Neurol. Neurosurg. Psychiatry</source>
<volume>90</volume>, <fpage>jnnp-2019-321400</fpage>&#x02013;<lpage>jnnp-2019-321360</lpage>. doi: <pub-id pub-id-type="doi">10.1136/jnnp-2019-321400</pub-id>, PMID: <pub-id pub-id-type="pmid">31256001</pub-id>
</mixed-citation></ref><ref id="ref109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruseler-van Embden</surname><given-names>J. G.</given-names></name><name><surname>van Lieshout</surname><given-names>L. M.</given-names></name><name><surname>Gosselink</surname><given-names>M. J.</given-names></name><name><surname>Marteau</surname><given-names>P.</given-names></name></person-group> (<year>1995</year>). <article-title>Inability of <italic>Lactobacillus casei</italic> strain GG, L. acidophilus, and <italic>Bifidobacterium bifidum</italic> to degrade intestinal mucus glycoproteins</article-title>. <source>Scand. J. Gastroenterol.</source>
<volume>30</volume>, <fpage>675</fpage>&#x02013;<lpage>680</lpage>. doi: <pub-id pub-id-type="doi">10.3109/00365529509096312</pub-id>, PMID: <pub-id pub-id-type="pmid">7481531</pub-id>
</mixed-citation></ref><ref id="ref110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadeh</surname><given-names>A.</given-names></name><name><surname>Keinan</surname><given-names>G.</given-names></name><name><surname>Daon</surname><given-names>K.</given-names></name></person-group> (<year>2004</year>). <article-title>Effects of stress on sleep: the moderating role of coping style</article-title>. <source>Health Psychol.</source>
<volume>23</volume>, <fpage>542</fpage>&#x02013;<lpage>545</lpage>. doi: <pub-id pub-id-type="doi">10.1037/0278-6133.23.5.542</pub-id>, PMID: <pub-id pub-id-type="pmid">15367075</pub-id>
</mixed-citation></ref><ref id="ref111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saper</surname><given-names>C. B.</given-names></name><name><surname>Scammell</surname><given-names>T. E.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>Hypothalamic regulation of sleep and circadian rhythms</article-title>. <source>Nature</source>
<volume>437</volume>, <fpage>1257</fpage>&#x02013;<lpage>1263</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature04284</pub-id>, PMID: <pub-id pub-id-type="pmid">16251950</pub-id>
</mixed-citation></ref><ref id="ref112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarasa</surname><given-names>S. B.</given-names></name><name><surname>Mahendran</surname><given-names>R.</given-names></name><name><surname>Muthusamy</surname><given-names>G.</given-names></name><name><surname>Thankappan</surname><given-names>B.</given-names></name><name><surname>Selta</surname><given-names>D. R. F.</given-names></name><name><surname>Angayarkanni</surname><given-names>J.</given-names></name></person-group> (<year>2020</year>). <article-title>A brief review on the non-protein amino acid, gamma-amino butyric acid (GABA): its production and role in microbes</article-title>. <source>Curr. Microbiol.</source>
<volume>77</volume>, <fpage>534</fpage>&#x02013;<lpage>544</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00284-019-01839-w</pub-id>, PMID: <pub-id pub-id-type="pmid">31844936</pub-id>
</mixed-citation></ref><ref id="ref113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaha</surname><given-names>D. P.</given-names></name></person-group> (<year>2023</year>). <article-title>Insomnia management: a review and update</article-title>. <source>J. Fam. Pract.</source>
<volume>72</volume>, <fpage>S31</fpage>&#x02013;<lpage>s36</lpage>. doi: <pub-id pub-id-type="doi">10.12788/jfp.0620</pub-id>, PMID: <pub-id pub-id-type="pmid">37549414</pub-id>
</mixed-citation></ref><ref id="ref114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shutta</surname><given-names>K. H.</given-names></name><name><surname>Balasubramanian</surname><given-names>R.</given-names></name><name><surname>Huang</surname><given-names>T.</given-names></name><name><surname>Jha</surname><given-names>S. C.</given-names></name><name><surname>Zeleznik</surname><given-names>O. A.</given-names></name><name><surname>Kroenke</surname><given-names>C. H.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Plasma metabolomic profiles associated with chronic distress in women</article-title>. <source>Psychoneuroendocrinology</source>
<volume>133</volume>:<fpage>105420</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.psyneuen.2021.105420</pub-id>, PMID: <pub-id pub-id-type="pmid">34597898</pub-id>
</mixed-citation></ref><ref id="ref115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shyken</surname><given-names>J. M.</given-names></name><name><surname>Babbar</surname><given-names>S.</given-names></name><name><surname>Babbar</surname><given-names>S.</given-names></name><name><surname>Forinash</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Benzodiazepines in Pregnancy</article-title>. <source>Clin. Obstet. Gynecol.</source>
<volume>62</volume>, <fpage>156</fpage>&#x02013;<lpage>167</lpage>. doi: <pub-id pub-id-type="doi">10.1097/grf.0000000000000417</pub-id>, PMID: <pub-id pub-id-type="pmid">30628916</pub-id>
</mixed-citation></ref><ref id="ref116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigel</surname><given-names>E.</given-names></name><name><surname>Ernst</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>The benzodiazepine binding sites of GABAA receptors</article-title>. <source>Trends Pharmacol. Sci.</source>
<volume>39</volume>, <fpage>659</fpage>&#x02013;<lpage>671</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tips.2018.03.006</pub-id>, PMID: <pub-id pub-id-type="pmid">29716746</pub-id>
</mixed-citation></ref><ref id="ref117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soghomonian</surname><given-names>J. J.</given-names></name><name><surname>Martin</surname><given-names>D. L.</given-names></name></person-group> (<year>1998</year>). <article-title>Two isoforms of glutamate decarboxylase: why?</article-title>
<source>Trends Pharmacol. Sci.</source>
<volume>19</volume>, <fpage>500</fpage>&#x02013;<lpage>505</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0165-6147(98)01270-x</pub-id>, PMID: <pub-id pub-id-type="pmid">9871412</pub-id>
</mixed-citation></ref><ref id="ref118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srichomphu</surname><given-names>P.</given-names></name><name><surname>Wattanathorn</surname><given-names>J.</given-names></name><name><surname>Thukham-Mee</surname><given-names>W.</given-names></name><name><surname>Muchimapura</surname><given-names>S.</given-names></name></person-group> (<year>2022</year>). <article-title>Anxiety, insomnia, and memory impairment in metabolic syndrome rats are alleviated by the novel functional ingredients from <italic>Anacardium occidentale</italic></article-title>. <source>Antioxidants (Basel)</source>
<volume>11</volume>:<fpage>2203</fpage>. doi: <pub-id pub-id-type="doi">10.3390/antiox11112203</pub-id>, PMID: <pub-id pub-id-type="pmid">36358575</pub-id>
</mixed-citation></ref><ref id="ref119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steel</surname><given-names>A.</given-names></name><name><surname>Mikkelsen</surname><given-names>M.</given-names></name><name><surname>Edden</surname><given-names>R. A. E.</given-names></name><name><surname>Robertson</surname><given-names>C. E.</given-names></name></person-group> (<year>2020</year>). <article-title>Regional balance between glutamate+glutamine and GABA+ in the resting human brain</article-title>. <source>NeuroImage</source>
<volume>220</volume>:<fpage>117112</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2020.117112</pub-id>, PMID: <pub-id pub-id-type="pmid">32619710</pub-id>
</mixed-citation></ref><ref id="ref120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sternbach</surname><given-names>L. H.</given-names></name></person-group> (<year>1978</year>). <article-title>The benzodiazepine story</article-title>. <source>Prog. Drug Res.</source>
<volume>22</volume>, <fpage>229</fpage>&#x02013;<lpage>266</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-3-0348-7102-0_5</pub-id><pub-id pub-id-type="pmid">30117</pub-id>
</mixed-citation></ref><ref id="ref121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strandwitz</surname><given-names>P.</given-names></name></person-group> (<year>2018</year>). <article-title>Neurotransmitter modulation by the gut microbiota</article-title>. <source>Brain Res.</source>
<volume>1693</volume>, <fpage>128</fpage>&#x02013;<lpage>133</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.brainres.2018.03.015</pub-id>, PMID: <pub-id pub-id-type="pmid">29903615</pub-id>
</mixed-citation></ref><ref id="ref122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strandwitz</surname><given-names>P.</given-names></name><name><surname>Kim</surname><given-names>K. H.</given-names></name><name><surname>Terekhova</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>J. K.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Levering</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>GABA-modulating bacteria of the human gut microbiota</article-title>. <source>Nat. Microbiol.</source>
<volume>4</volume>, <fpage>396</fpage>&#x02013;<lpage>403</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41564-018-0307-3</pub-id>, PMID: <pub-id pub-id-type="pmid">30531975</pub-id>
</mixed-citation></ref><ref id="ref123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Streeter</surname><given-names>C. C.</given-names></name><name><surname>Whitfield</surname><given-names>T. H.</given-names></name><name><surname>Owen</surname><given-names>L.</given-names></name><name><surname>Rein</surname><given-names>T.</given-names></name><name><surname>Karri</surname><given-names>S. K.</given-names></name><name><surname>Yakhkind</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study</article-title>. <source>J. Altern. Complement. Med.</source>
<volume>16</volume>, <fpage>1145</fpage>&#x02013;<lpage>1152</lpage>. doi: <pub-id pub-id-type="doi">10.1089/acm.2010.0007</pub-id>, PMID: <pub-id pub-id-type="pmid">20722471</pub-id>
</mixed-citation></ref><ref id="ref124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su&#x000e1;rez-Pereira</surname><given-names>I.</given-names></name><name><surname>Llorca-Torralba</surname><given-names>M.</given-names></name><name><surname>Bravo</surname><given-names>L.</given-names></name><name><surname>Camarena-Delgado</surname><given-names>C.</given-names></name><name><surname>Soriano-Mas</surname><given-names>C.</given-names></name><name><surname>Berrocoso</surname><given-names>E.</given-names></name></person-group> (<year>2022</year>). <article-title>The role of the locus Coeruleus in pain and associated stress-related disorders</article-title>. <source>Biol. Psychiatry</source>
<volume>91</volume>, <fpage>786</fpage>&#x02013;<lpage>797</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopsych.2021.11.023</pub-id>, PMID: <pub-id pub-id-type="pmid">35164940</pub-id>
</mixed-citation></ref><ref id="ref125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takanaga</surname><given-names>H.</given-names></name><name><surname>Ohtsuki</surname><given-names>S.</given-names></name><name><surname>Hosoya</surname><given-names>K.</given-names></name><name><surname>Terasaki</surname><given-names>T.</given-names></name></person-group> (<year>2001</year>). <article-title>GAT2/BGT-1 as a system responsible for the transport of gamma-aminobutyric acid at the mouse blood-brain barrier</article-title>. <source>J. Cereb. Blood Flow Metab.</source>
<volume>21</volume>, <fpage>1232</fpage>&#x02013;<lpage>1239</lpage>. doi: <pub-id pub-id-type="doi">10.1097/00004647-200110000-00012</pub-id>, PMID: <pub-id pub-id-type="pmid">11598501</pub-id>
</mixed-citation></ref><ref id="ref126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>M.</given-names></name><name><surname>Bhagwagar</surname><given-names>Z.</given-names></name><name><surname>Cowen</surname><given-names>P. J.</given-names></name><name><surname>Sharp</surname><given-names>T.</given-names></name></person-group> (<year>2003</year>). <article-title>GABA and mood disorders</article-title>. <source>Psychol. Med.</source>
<volume>33</volume>, <fpage>387</fpage>&#x02013;<lpage>393</lpage>. doi: <pub-id pub-id-type="doi">10.1017/s0033291702006876</pub-id>, PMID: <pub-id pub-id-type="pmid">12701660</pub-id>
</mixed-citation></ref><ref id="ref127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thwaites</surname><given-names>D. T.</given-names></name><name><surname>Basterfield</surname><given-names>L.</given-names></name><name><surname>McCleave</surname><given-names>P. M.</given-names></name><name><surname>Carter</surname><given-names>S. M.</given-names></name><name><surname>Simmons</surname><given-names>N. L.</given-names></name></person-group> (<year>2000</year>). <article-title>Gamma-aminobutyric acid (GABA) transport across human intestinal epithelial (Caco-2) cell monolayers</article-title>. <source>Br. J. Pharmacol.</source>
<volume>129</volume>, <fpage>457</fpage>&#x02013;<lpage>464</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.bjp.0703069</pub-id>, PMID: <pub-id pub-id-type="pmid">10711343</pub-id>
</mixed-citation></ref><ref id="ref128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toth</surname><given-names>E.</given-names></name><name><surname>Lajtha</surname><given-names>A.</given-names></name></person-group> (<year>1981</year>). <article-title>Elevation of cerebral levels of nonessential amino acids <italic>in vivo</italic> by administration of large doses</article-title>. <source>Neurochem. Res.</source>
<volume>6</volume>, <fpage>1309</fpage>&#x02013;<lpage>1317</lpage>. doi: <pub-id pub-id-type="doi">10.1007/bf00964352</pub-id>, PMID: <pub-id pub-id-type="pmid">6122166</pub-id>
</mixed-citation></ref><ref id="ref129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Gelder</surname><given-names>N. M.</given-names></name><name><surname>Elliott</surname><given-names>K. A.</given-names></name></person-group> (<year>1958</year>). <article-title>Disposition of gamma-aminobutyric acid administered to mammals</article-title>. <source>J. Neurochem.</source>
<volume>3</volume>, <fpage>139</fpage>&#x02013;<lpage>143</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1471-4159.1958.tb12620.x</pub-id><pub-id pub-id-type="pmid">13621235</pub-id>
</mixed-citation></ref><ref id="ref130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Someren</surname><given-names>E. J. W.</given-names></name></person-group> (<year>2021</year>). <article-title>Brain mechanisms of insomnia: new perspectives on causes and consequences</article-title>. <source>Physiol. Rev.</source>
<volume>101</volume>, <fpage>995</fpage>&#x02013;<lpage>1046</lpage>. doi: <pub-id pub-id-type="doi">10.1152/physrev.00046.2019</pub-id>, PMID: <pub-id pub-id-type="pmid">32790576</pub-id>
</mixed-citation></ref><ref id="ref131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vann</surname><given-names>K.</given-names></name><name><surname>Techaparin</surname><given-names>A.</given-names></name><name><surname>Apiraksakorn</surname><given-names>J.</given-names></name></person-group> (<year>2020</year>). <article-title>Beans germination as a potential tool for GABA-enriched tofu production</article-title>. <source>J. Food Sci. Technol.</source>
<volume>57</volume>, <fpage>3947</fpage>&#x02013;<lpage>3954</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s13197-020-04423-4</pub-id>, PMID: <pub-id pub-id-type="pmid">33071316</pub-id>
</mixed-citation></ref><ref id="ref132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verret</surname><given-names>L.</given-names></name><name><surname>Fort</surname><given-names>P.</given-names></name><name><surname>Gervasoni</surname><given-names>D.</given-names></name><name><surname>L&#x000e9;ger</surname><given-names>L.</given-names></name><name><surname>Luppi</surname><given-names>P. H.</given-names></name></person-group> (<year>2006</year>). <article-title>Localization of the neurons active during paradoxical (REM) sleep and projecting to the locus coeruleus noradrenergic neurons in the rat</article-title>. <source>J. Comp. Neurol.</source>
<volume>495</volume>, <fpage>573</fpage>&#x02013;<lpage>586</lpage>. doi: <pub-id pub-id-type="doi">10.1002/cne.20891</pub-id><pub-id pub-id-type="pmid">16498678</pub-id>
</mixed-citation></ref><ref id="ref133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vertes</surname><given-names>R. P.</given-names></name></person-group> (<year>2004</year>). <article-title>Differential projections of the infralimbic and prelimbic cortex in the rat</article-title>. <source>Synapse</source>
<volume>51</volume>, <fpage>32</fpage>&#x02013;<lpage>58</lpage>. doi: <pub-id pub-id-type="doi">10.1002/syn.10279</pub-id>, PMID: <pub-id pub-id-type="pmid">14579424</pub-id>
</mixed-citation></ref><ref id="ref134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vu</surname><given-names>V.</given-names></name><name><surname>Conant-Norville</surname><given-names>D.</given-names></name></person-group> (<year>2021</year>). <article-title>Anxiety: recognition and treatment options</article-title>. <source>Psychiatr. Clin. North Am.</source>
<volume>44</volume>, <fpage>373</fpage>&#x02013;<lpage>380</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.psc.2021.04.005</pub-id>, PMID: <pub-id pub-id-type="pmid">34372994</pub-id>
</mixed-citation></ref><ref id="ref135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warner</surname><given-names>E. N.</given-names></name><name><surname>Strawn</surname><given-names>J. R.</given-names></name></person-group> (<year>2023</year>). <article-title>Risk factors for pediatric anxiety disorders</article-title>. <source>Child Adolesc. Psychiatr. Clin. N. Am.</source>
<volume>32</volume>, <fpage>485</fpage>&#x02013;<lpage>510</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chc.2022.10.001</pub-id>, PMID: <pub-id pub-id-type="pmid">37201963</pub-id>
</mixed-citation></ref><ref id="ref136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>T.</given-names></name><name><surname>Hayashi</surname><given-names>K.</given-names></name><name><surname>Takara</surname><given-names>T.</given-names></name><name><surname>Teratani</surname><given-names>T.</given-names></name><name><surname>Kitayama</surname><given-names>J.</given-names></name><name><surname>Kawahara</surname><given-names>T.</given-names></name></person-group> (<year>2022</year>). <article-title>Effect of Oral Administration of Lactiplantibacillus plantarum SNK12 on temporary stress in adults: a randomized, placebo-controlled, double-blind, parallel-group study</article-title>. <source>Int. J. Environ. Res. Public Health</source>
<volume>19</volume>:<fpage>8936</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph19158936</pub-id>, PMID: <pub-id pub-id-type="pmid">35897310</pub-id>
</mixed-citation></ref><ref id="ref137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>M. L.</given-names></name><name><surname>Kling</surname><given-names>M. A.</given-names></name><name><surname>Munson</surname><given-names>P. J.</given-names></name><name><surname>Listwak</surname><given-names>S.</given-names></name><name><surname>Licinio</surname><given-names>J.</given-names></name><name><surname>Prolo</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2000</year>). <article-title>Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>
<volume>97</volume>, <fpage>325</fpage>&#x02013;<lpage>330</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.97.1.325</pub-id>, PMID: <pub-id pub-id-type="pmid">10618417</pub-id>
</mixed-citation></ref><ref id="ref138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>A.</given-names></name><name><surname>Shu</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2022</year>). <article-title><italic>Lactobacillus plantarum</italic>-derived postbiotics prevent Salmonella-induced neurological dysfunctions by modulating gut-brain axis in mice</article-title>. <source>Front. Nutr.</source>
<volume>9</volume>:<fpage>946096</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnut.2022.946096</pub-id>, PMID: <pub-id pub-id-type="pmid">35967771</pub-id>
</mixed-citation></ref><ref id="ref139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>T.</given-names></name><name><surname>Liao</surname><given-names>J.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Fan</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title>Impairment of GABA inhibition in insomnia disorders: evidence from the peripheral blood system</article-title>. <source>Front. Psych.</source>
<volume>14</volume>:<fpage>1134434</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyt.2023.1134434</pub-id>, PMID: <pub-id pub-id-type="pmid">36846238</pub-id>
</mixed-citation></ref><ref id="ref140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamatsu</surname><given-names>A.</given-names></name><name><surname>Yamashita</surname><given-names>Y.</given-names></name><name><surname>Maru</surname><given-names>I.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Tatsuzaki</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>The improvement of sleep by Oral intake of GABA and Apocynum venetum leaf extract</article-title>. <source>J. Nutr. Sci. Vitaminol. (Tokyo)</source>
<volume>61</volume>, <fpage>182</fpage>&#x02013;<lpage>187</lpage>. doi: <pub-id pub-id-type="doi">10.3177/jnsv.61.182</pub-id>, PMID: <pub-id pub-id-type="pmid">26052150</pub-id>
</mixed-citation></ref><ref id="ref141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamatsu</surname><given-names>A.</given-names></name><name><surname>Yamashita</surname><given-names>Y.</given-names></name><name><surname>Pandharipande</surname><given-names>T.</given-names></name><name><surname>Maru</surname><given-names>I.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Effect of oral &#x003b3;-aminobutyric acid (GABA) administration on sleep and its absorption in humans</article-title>. <source>Food Sci. Biotechnol.</source>
<volume>25</volume>, <fpage>547</fpage>&#x02013;<lpage>551</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10068-016-0076-9</pub-id>, PMID: <pub-id pub-id-type="pmid">30263304</pub-id>
</mixed-citation></ref><ref id="ref142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>L.</given-names></name><name><surname>Zheng</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Jin</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>UV-C treatment enhances organic acids and GABA accumulation in tomato fruits during storage</article-title>. <source>Food Chem.</source>
<volume>338</volume>:<fpage>128126</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.foodchem.2020.128126</pub-id>, PMID: <pub-id pub-id-type="pmid">33091993</pub-id>
</mixed-citation></ref><ref id="ref143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>S. S.</given-names></name><name><surname>Gujar</surname><given-names>N.</given-names></name><name><surname>Hu</surname><given-names>P.</given-names></name><name><surname>Jolesz</surname><given-names>F. A.</given-names></name><name><surname>Walker</surname><given-names>M. P.</given-names></name></person-group> (<year>2007</year>). <article-title>The human emotional brain without sleep--a prefrontal amygdala disconnect</article-title>. <source>Curr. Biol.</source>
<volume>17</volume>, <fpage>R877</fpage>&#x02013;<lpage>R878</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cub.2007.08.007</pub-id><pub-id pub-id-type="pmid">17956744</pub-id>
</mixed-citation></ref><ref id="ref144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoto</surname><given-names>A.</given-names></name><name><surname>Murao</surname><given-names>S.</given-names></name><name><surname>Motoki</surname><given-names>M.</given-names></name><name><surname>Yokoyama</surname><given-names>Y.</given-names></name><name><surname>Horie</surname><given-names>N.</given-names></name><name><surname>Takeshima</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Oral intake of &#x003b3;-aminobutyric acid affects mood and activities of central nervous system during stressed condition induced by mental tasks</article-title>. <source>Amino Acids</source>
<volume>43</volume>, <fpage>1331</fpage>&#x02013;<lpage>1337</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00726-011-1206-6</pub-id>, PMID: <pub-id pub-id-type="pmid">22203366</pub-id>
</mixed-citation></ref><ref id="ref145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zafar</surname><given-names>S.</given-names></name><name><surname>Jabeen</surname><given-names>I.</given-names></name></person-group> (<year>2018</year>). <article-title>Structure, function, and modulation of &#x003b3;-aminobutyric acid transporter 1 (GAT1) in neurological disorders: a Pharmacoinformatic prospective</article-title>. <source>Front. Chem.</source>
<volume>6</volume>:<fpage>397</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fchem.2018.00397</pub-id>, PMID: <pub-id pub-id-type="pmid">30255012</pub-id>
</mixed-citation></ref><ref id="ref146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zawistowska-Rojek</surname><given-names>A.</given-names></name><name><surname>Tyski</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Are probiotic really safe for humans?</article-title>
<source>Pol. J. Microbiol.</source>
<volume>67</volume>, <fpage>251</fpage>&#x02013;<lpage>258</lpage>. doi: <pub-id pub-id-type="doi">10.21307/pjm-2018-044</pub-id>, PMID: <pub-id pub-id-type="pmid">30451441</pub-id>
</mixed-citation></ref><ref id="ref147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Deng</surname><given-names>Z.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name></person-group> (<year>2024</year>). <article-title>Multi-omics reveal the improvements of nutrient digestion, absorption, and metabolism and intestinal function via GABA supplementation in weanling piglets</article-title>. <source>Animals (Basel)</source>
<volume>14</volume>:<fpage>3177</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ani14223177</pub-id>, PMID: <pub-id pub-id-type="pmid">39595230</pub-id>
</mixed-citation></ref><ref id="ref148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Lam</surname><given-names>S. P.</given-names></name><name><surname>Li</surname><given-names>S. X.</given-names></name><name><surname>Ma</surname><given-names>R. C.</given-names></name><name><surname>Kong</surname><given-names>A. P.</given-names></name><name><surname>Chan</surname><given-names>M. H.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>A community-based study on the association between insomnia and hypothalamic-pituitary-adrenal axis: sex and pubertal influences</article-title>. <source>J. Clin. Endocrinol. Metab.</source>
<volume>99</volume>, <fpage>2277</fpage>&#x02013;<lpage>2287</lpage>. doi: <pub-id pub-id-type="doi">10.1210/jc.2013-3728</pub-id><pub-id pub-id-type="pmid">24617708</pub-id>
</mixed-citation></ref><ref id="ref149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Vogelzang</surname><given-names>A.</given-names></name><name><surname>Miyajima</surname><given-names>M.</given-names></name><name><surname>Sugiura</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Chamoto</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>B cell-derived GABA elicits IL-10(+) macrophages to limit anti-tumour immunity</article-title>. <source>Nature</source>
<volume>599</volume>, <fpage>471</fpage>&#x02013;<lpage>476</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41586-021-04082-1</pub-id>, PMID: <pub-id pub-id-type="pmid">34732892</pub-id>
</mixed-citation></ref><ref id="ref150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>W.</given-names></name><name><surname>Ge</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>A study on quality components and sleep-promoting effects of GABA black tea</article-title>. <source>Food Funct.</source>
<volume>6</volume>, <fpage>3393</fpage>&#x02013;<lpage>3398</lpage>. doi: <pub-id pub-id-type="doi">10.1039/c5fo00265f</pub-id>, PMID: <pub-id pub-id-type="pmid">26290415</pub-id>
</mixed-citation></ref><ref id="ref151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>N.</given-names></name><name><surname>Shu</surname><given-names>Y.</given-names></name><name><surname>Jian</surname><given-names>C.</given-names></name><name><surname>Zhou</surname><given-names>Z.</given-names></name><name><surname>Bao</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2022</year>). <article-title>Lactobacillus ameliorates SD-induced stress responses and gut Dysbiosis by increasing the absorption of gut-derived GABA in Rhesus monkeys</article-title>. <source>Front. Immunol.</source>
<volume>13</volume>:<fpage>915393</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.915393</pub-id>, PMID: <pub-id pub-id-type="pmid">35874738</pub-id>
</mixed-citation></ref><ref id="ref152"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>B.</given-names></name><name><surname>Jin</surname><given-names>G.</given-names></name><name><surname>Pang</surname><given-names>X.</given-names></name><name><surname>Mo</surname><given-names>Q.</given-names></name><name><surname>Bao</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2022</year>). <article-title><italic>Lactobacillus rhamnosus</italic> GG colonization in early life regulates gut-brain axis and relieves anxiety-like behavior in adulthood</article-title>. <source>Pharmacol. Res.</source>
<volume>177</volume>:<fpage>106090</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.phrs.2022.106090</pub-id>, PMID: <pub-id pub-id-type="pmid">35065201</pub-id>
</mixed-citation></ref><ref id="ref153"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Wen</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name></person-group> (<year>2022</year>). <article-title>Depression-like symptoms due to Dcf1 deficiency are alleviated by intestinal transplantation of Lactobacillus murine and <italic>Lactobacillus reuteri</italic></article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>593</volume>, <fpage>137</fpage>&#x02013;<lpage>143</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbrc.2022.01.026</pub-id>, PMID: <pub-id pub-id-type="pmid">35066403</pub-id>
</mixed-citation></ref><ref id="ref154"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Xie</surname><given-names>S. Z.</given-names></name><name><surname>Peng</surname><given-names>A. B.</given-names></name><name><surname>Yu</surname><given-names>X. D.</given-names></name><name><surname>Li</surname><given-names>C. Y.</given-names></name><name><surname>Fu</surname><given-names>J. Y.</given-names></name><etal/></person-group>. (<year>2024</year>). <article-title>Distinct circuits from the central lateral amygdala to the ventral part of the bed nucleus of Stria Terminalis regulate different fear memory</article-title>. <source>Biol. Psychiatry</source>
<volume>95</volume>, <fpage>732</fpage>&#x02013;<lpage>744</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopsych.2023.08.022</pub-id>, PMID: <pub-id pub-id-type="pmid">37678543</pub-id>
</mixed-citation></ref></ref-list></back></article>